Abstract
The fields of regenerative medicine and stem cell-based tissue engineering have the potential of treating numerous tissue and organ defects. The use of adult stem cells is of particular interest when it comes to dynamic applications in translational medicine. Recently, dental pulp stem cells (DPSCs) have been traced in third molars of adult humans. DPSCs have been isolated and characterized by several groups. DPSCs have promising characteristics including self-renewal capacity, rapid proliferation, colony formation, multi-lineage differentiation, and pluripotent gene expression profile. Nevertheless, genotypic, and phenotypic heterogeneities have been reported for DPSCs subpopulations which may influence their therapeutic potentials. The underlying causes of DPSCs’ heterogeneity remain poorly understood; however, their heterogeneity emerges as a consequence of an interplay between intrinsic and extrinsic cellular factors. The main objective of the manuscript is to review the current literature related to the human DPSCs derived from the third molar, with a focus on their physiological properties, isolation procedures, culture conditions, self-renewal, proliferation, lineage differentiation capacities and their prospective advances use in pre-clinical and clinical applications.
Introduction
Dental pulp stem cells (DPSCs) are a unique population of cells embedded within the pulp cavity of the impacted third molars. DPSCs were initially isolated and characterized by Gronthos et al. (2000). Subsequently, several investigators have reported DPSCs’ isolation, characterization, differentiation, and banking (Atari et al., 2012; Ferro et al., 2012a; Tirino et al., 2012). In comparison to other adult stem cells, DPSCs are noted for their high recovery rate from the disposable dental pulp after occlusion management. Their isolation procedure involves non-invasive techniques and has no notable ethical constraints. Significantly, DPSCs’ stemness, viability, proliferation, and differentiating capabilities are not compromised after cryopreservation (Zhang et al., 2006; Pilbauerova et al., 2021b). Therefore, DPSCs have the potential to be a promising personalized patient-specific stem cells source for regenerative therapy. In this review article, we will discuss the tooth anatomy and dental stem cells with a particular interest on the current advances in adult human DPSCs including their origin, biological characteristics, heterogenicity, differentiation, and immunomodulatory potentials, as well as paracrine effects and pre-clinical and clinical applications.
Anatomical Structure of the Tooth
Teeth are viable organs made up of well-organized structures with numerous but defined specific shapes (Magnusson, 1968). Odontogenesis or teeth generation undergoes several complex developmental stages that are yet to be fully defined (Smith, 1998; Zheng et al., 2014; Rathee and Jain, 2021). Remarkably, the tooth tissues originate from different cell lineages. The enamel develops from cells derived from the ectoderm of the oral cavity, whereas the cementum, dentin, and pulp tissues are derived from neural crest-mesenchyme cells of ectodermal and mesodermal origins (Figure 1A; Miletich and Sharpe, 2004; Thesleff and Tummers, 2008; Caton and Tucker, 2009; Koussoulakou et al., 2009). The lineage diversities may explain the observed differences in tissue topography and physiological function. The enamel-producing cells and associated metabolites are lost during tooth eruption, whereas pulp cells are longevous and have the capacity to undergo remodeling and regeneration (Simon et al., 2014).
FIGURE 1

Oral tissue and dental stem cells. (A) A schematic outline for the tooth development. Ectoderm cells contribute to the formation of the tooth enamel only, whereas, neural crest cells generate the rest of the tooth tissues. (B) Sources of oral tissue and dental stem cells. GMSCs, gingiva-derived mesenchymal stem cells; DFPCs, dental follicle precursor cells; SCAP, stem cells from apical papilla; PDLSCs, periodontal ligament stem cells; DPSCs, dental pulp stem cells; SHED, stem cells from human exfoliated deciduous teeth, ABMSCs, alveolar bone–derived mesenchymal stem cell. (C) A schematic illustration of the dental stem cells multilineage differentiation potential. Created with BioRender.com.
The dental pulp is a highly vascularized connective tissue, consists of four zones, namely (1) the peripheral odontogenic zone, (2) intermediate cell-free zone, (3) cell-rich zone, and (4) the pulp core (Figure 1A, insert). Adjacent to the dentin layer, the peripheral odontogenic zone contains the specialized columnar odontoblast cells that produce dentin (Gotjamanos, 1969; Sunitha et al., 2008; Pang et al., 2016; Ghannam et al., 2021). Besides the extensive vascular and neuronal network, the cell-free zone or basal layer of Weil contains a small number of cells whereas, high density of specialized cells is observed in the underlying zones. The cell-rich zone contains fibroblasts, macrophages, capillaries and proliferating mesenchymal cells that can differentiate into odontoblasts. The pulp core is populated by multiple populations of dental mesenchymal cells, mesenchymal-like stem cells, macrophages and dendritic cells that maintain the dentin-pulp complex functionality and homeostasis (Berkovitz, 1989; Abd-Elmeguid and Yu, 2009; Farges et al., 2015).
Stem Cells in the Tooth Compartments
Like other organs, tooth compartments harbor a niche of heterogeneous stem/progenitor cell populations of the embryonic stem cells; however, the developmental stage for most dental stem cells has not been established yet and their precise role remains poorly understood (Kaukua et al., 2014; Krivanek et al., 2017). Several studies have indicated that in mild tooth trauma and post-inflammatory recovery, these cells regenerate dentin barrier to protect the pulp from infectious agents and demonstrate an immunomodulatory capacity, either via secreting proinflammatory cytokines or through crosstalk with immune cells (Lesot, 2000; Tomic et al., 2011; Hosoya et al., 2012; Leprince et al., 2012; Li et al., 2014).
The various sources of dental progenitor cells include the DPSCs (Gronthos et al., 2000), stem cells from human exfoliated deciduous teeth (SHED) (Miura et al., 2003), periodontal ligament stem cells (PDLSCs) (Seo et al., 2004), dental follicle stem cells (DFSCs) (Morsczeck et al., 2005), stem cells from apical papilla (SCAP) (Sonoyama et al., 2006, 2008), and gingival stem cells (GING SCs) (Mitrano et al., 2010; Figure 1B). Like bone marrow-derived mesenchymal stem cells (BM-MSCs), dental progenitor/stem cells exhibit self-renewal capacity and multilineage differentiation potential. In vitro studies have shown that dental stem cells generate clonogenic cell clusters, possess high proliferation rates and have the potential of multi-lineage differentiation into a wide spectrum of cell types from the three germ layers or, at least in part, express their specific markers under the appropriate culture conditions (Figure 1C). Despite being similar at a coarse level, the transcriptomic and proteomic profiles of oral stem cells reveal several molecular differences including differential expression of surface marker, structural proteins, growth hormones, and metabolites; indicating prospective developmental divergence (Hosmani et al., 2020; Krivanek et al., 2020), and also suggest that dental stem cells might be the optimal choice for tissue self-repair and regeneration.
Dental Stem Cell Lineage Tracing
The plasticity and multi-potential competency of oral stem cells owe to the fact that the dental pulp contains neuro-mesenchymal components. Genetic lineage tracing studies have identified the perivascular pericytes and glial cells as immediate ancestors of the dental stem cells. Utilizing mouse incisors’ regenerative capacity as a model for recovery from pulp/dentin injury, Feng et al. (2011) identified the pericytes NG+ cells as oligodendrocyte progenitors. Post trauma, pericytes NG+ cells proliferate rapidly and partially contribute to the generated odontoblasts (Pang et al., 2016). Later, Zhao et al. (2014) reported the role of neurovascular sensory cells in activating periarterial Gli1+ cells through sonic hedgehog signaling pathways, which were sufficient to maintain homeostasis and injury repair of the incisor mesenchyme. Notably, lineage tracing studies revealed that Gli1+ cells contributed to the entire pericytes NG+ cell population, but not vice versa (Zhao et al., 2014). Therefore, periarterial Gli1+ cells are believed to be the sole source of odontoblast derivation. These observations were further supported experimentally by combining a clonal color-coding technique with tracing of peripheral glia cells, in addition, quantification analysis revealed that both pericytes and glial cells contribute equally to the dynamics of tooth organogenesis, homeostasis, and growth (Kaukua et al., 2014; Sharpe, 2016; Shi et al., 2020).
Dental Pulp Stem Cells Isolation Procedures and Culture Conditions
Dental pulp stem cells constitute merely 5% of the pulp cells and they were first isolated and characterized by Gronthos et al. (2000). The quality of the isolated DPSCs primarily impacts their regenerative potential. The culturing method and accurate characterization are pivotal steps for the isolation of high-quality DPSCs. Following extraction of the third molar, further procedures include mechanical extraction of the soft pulp connective tissue, maceration, enzymatic digestion of extracellular matrix proteins (ECM), and cell growth in plastic tissue/cell culture plates. The various isolation and culture procedures used for the human DPSCs have been best reviewed by Rodas-Junco and Villicana (2017).
Here, we also describe the standard procedure used in our clinic and laboratory. Briefly, immediately after extraction, the third molar is thoroughly rinsed with ethanol and sterile distilled water. Using a cylindrical turbine bur, an incision is made between the enamel and the cement at the point of molar fracture. The fragmented tooth is refreshed in PBS in sterile tubes and rushed to the laboratory. Using aseptic techniques, the tooth is transferred to a petri dish and dental pulp tissue is isolated using a sterile nerve-puller file-15 and forceps, chopped into fine fragments and digested by collagenase type I for 60 min at 37°C. Single cell suspension is prepared by first passing cells through an insulin syringe and then passing through cell strainer with 40 μm APD, followed by centrifugation. The cell fraction is washed with sterile PBS, counted and cells are seeded in culture medium. For primary culture establishment, cells are seeded in fibronectin-coated culture dishes. At 60% confluency, DPSCs are passed at a cell density of 80–100 cells/cm2. DPSCs expansion medium consists of 60% DMEM-low glucose and 40% chick fibroblast basal medium MCDB-201, supplemented with a myriad of factors such as Insulin-Transferrin-Selenium (ITS), linoleic acid bovine serum albumin (LA-BSA), dexamethasone (dex), ascorbic acid 2-phosphate (Asc-2P), antibiotics (Penicillin/Streptomycin), human Platelet-Derived Growth Factor (hPDGF)-BB, human Epidermal Growth Factor (hEGF), human Leukemia Inhibitory Factor (hLIF), Chemically Defined Lipid Concentrate (CDLC), and β-mercaptoethanol (Atari et al., 2012; Martinez-Sarra et al., 2017; Nunez-Toldra et al., 2017a,b; Al Madhoun et al., 2018; Faruqu et al., 2020).
Dental Pulp Stem Cells Markers
Dental pulp stem cells are a heterogeneous mixture of cell populations with no distinct cell surface antigens (Kawashima, 2012). DPSCs display characteristics that are much similar to those of MSCs such as the abilities for self-renewal and multilineage differentiation. According to the minimal criteria defined by the International Society of Cellular Therapy (ISCT) for the human MSCs, these cells adhere to plastic, express CD29, CD44, CD49a-f, CD51, CD73 (SH3), CD90, CD105 (SH2), CD106, and CD166, and lack the expression of the hemopoietic surface antigens including CD11b, CD14, CD19, CD34, CD45, CD79a, and human leukocyte antigen-DR isotype (HLA-DR) (Dominici et al., 2006; Sonoyama et al., 2006; Huang et al., 2009; Wu et al., 2015). DPSCs express a wide spectrum of other surface markers also as shown in Table 1. However, notable complexity and divergence in their expression levels have been reported by several groups (Laino et al., 2005; Yamada et al., 2010; Hilkens et al., 2013; Niehage et al., 2016; Alraies et al., 2020) which could be attributed, at least in part, to their heterogenicity. DPSCs can be enriched by using different isolation procedures and cell culture conditions. For example, their surface marker expression may vary depending on the serum concentrations and/or the addition of growth factors to the basal culture media. Martens et al. (2012) have documented expression of the neural markers (nestin, vimentin, synaptophysin, S100, and βIII-tubulin) on undifferentiated DPSCs that were cultured in media containing 10% FBS. Longoni et al. (2020) reported fibrous cartilage tissue conversion (expression of aggrecan, glycosaminoglycan, elevated expression of collagen type I, and limited expression of collagen type II) of DPSCs using chondro-inductive growth factors such as insulin-like growth factor (IGF)-1, transforming growth factor (TGF)-β3, and bone morphogenetic protein (BMP)-2, -6, -7. Notably, Zhang et al. (2008) have reported adipogenic, myogenic, and odontogenic plasticity of the DPSCs using respective lineage-specific pre-inductions media in vitro.
TABLE 1
Surface markers and pre-lineages expression profile of dental pulp stem cells (DPSCs).
Antibody-based methods, proteomics and RNA transcriptomics are the main procedures used for DPSCs immunophenotyping. Besides the MSCs markers, DPSCs possess the embryonic stem cell-specific markers (Table 1). In addition, DPSCs express a variety of antigens associated with cell adhesion, growth factors, transcription regulation and multiple lineage-specific markers related to perivascular tissue, endothelium, immunogenic, neuronal and osteo/odontogenic tissues (Table 1). It is also noteworthy to mention that DPSCs express Major Histocompatibility Complex (MHC) class I antigens, but they do not express the immune co-stimulating molecules such as MHC class II antigen HLA-DR, CD40, CD80, and CD86 (Wada et al., 2009; Bhandi et al., 2021; Pilbauerova et al., 2021a).
Heterogeneity of Dental Pulp Stem Cells
The heterogeneity of the DPSCs subpopulations isolated from different donors is mainly influenced by donor health, age, genetic, and environmental factors (Kellner et al., 2014; Wu et al., 2015; Alraies et al., 2017; Kobayashi et al., 2020; Longoni et al., 2020). Alternatively, the intra-population heterogeneity refers to the DPSCs subpopulations found within the preparation from a single individual. The evidence demonstrating that DPSCs populations are functionally heterogeneous comes largely from their surface antigen profile or expression patterns of a variety of markers that are associated with progenitors of different lineages. DPSCs show surface expression of STRO-1, CD13, CD29, CD44, CD73, CD90, CD105, CD146, and CD166 – a profile which is reminiscent of BM-MSCs (Table 1), while DPSCs lack the expression of hematopoietic (CD34 and CD45) and monocytic (CD14) markers (Yamada et al., 2010). Additionally, DPSCs express various pluripotency markers, such as Oct-3/4, Nanog, and Sox-2, i.e., the stemness-related markers observed in embryonic stem cells (Table 1) which explains, at least in part, their self-renewal potential (Atari et al., 2011, 2012; Ferro et al., 2012b; Faruqu et al., 2020). As neuronal crest-derived cells, DPSCs express several neural stem cell markers, including nestin, neuronal nuclei antigen, vimentin, synaptophysin, musashi-1, Galactosyl-ceramidase, S100 calcium binding protein B, neurofilament heavy (NFH) chain, class III β-tubulin, and neurofilaments (Table 1). Thus, DPSCs are comprised of the progenitor cells that are marked by diverse characteristics, such as clonal heterogeneity, multi-lineage differentiation, self-renewal capacity, and phenotypic complexity.
Notably, specific conditions and media components used may act as a source of potential phenotypic and functional changes in the freshly extracted DPSCs. The isolation procedures may also influence their heterogeneity. Whereas, DPSCs isolation by enzymatic digestion provides a large number of cells at low passage rate, the tissue explants enable the isolation of a more homogeneous cell population (Bronckaers et al., 2013; Raoof et al., 2014). Furthermore, DPSCs heterogeneity is impacted by the culture media components, serum concentration, and growth factors supplements, all of which have been well-reviewed by Rodas-Junco and Villicana (2017). Moreover, long-term and large-scale expansion in culture may also impact the heterogeneity, survival, and differentiation potential of DPSCs. The selection and expansion of different DPSCs subpopulations driven by specific culture conditions, media supplementation and 2D/3D culture systems may collectively alter the cellular profile, homeostasis, plasticity, and regenerative potential, as well as immunomodulatory properties of DPSCs (further elaborated below).
Dental Pulp Stem Cells Crosstalk With Microenvironment in Homeostasis
Dental pulp stem cells are located within a heterogenic niche. Homeostatic regulation of the DPSCs niche, DPSCs’ proliferation and differentiation implicate a complex network of bioactive molecules, growth factors, ECM, and key signaling pathways (Scheller et al., 2008; Mitsiadis et al., 2011; Tsutsui, 2020; Deng et al., 2021). Nevertheless, the signals that regulate DPSC fate are not only the biochemical cues, but also the biophysical cues (mechanical signals) that play a crucial role in influencing DPSC fate since orthodontic mechanical tension or stresses are exerted to teeth and transmitted into the dental pulp tissue by jaw movement during the process of normal mastication (Tatullo et al., 2016). Thus, DPSCs are mechanosensitive cells by default with the capacity to recognize mechanical signals and transform these stimuli into various cellular responses to sustain niche homeostasis (Han et al., 2008, 2010; Hata et al., 2013). Importantly, Marrelli et al. (2018) have presented an excellent review of the mechanobiology and mechanoresponsiveness of DPSCs, deciphering how the mechanical stimuli might regulate behavior, fate, and homeostasis of DPSCs. These studies may enhance our understanding and improve approaches to the DPSC-based tissue engineering applications.
Dental Pulp Stem Cells Potential Role in Tissue Repair and Flourishment
Dental pulp stem cells could be valuable source for cell therapy and advancing the current regenerative medicine strategies. DPSCs plasticity to surrounding environment has made them a notable source for disease treatment, though the full understanding of DPSCs tissue repair mechanisms is still in their preliminary stages. In this section, we will review the current advances in DPSCs in vitro differentiation potentials and the capability to secrete growth factors that may contribute to their role in tissue repair.
Differentiation Potential of Dental Pulp Stem Cells
Due to their potential to differentiate into several cell lineages (Figure 1C), DPSCs have received extensive attention in the field of regenerative medicine and tissue engineering. DPSCs have the potential to differentiate into endodermal (respiratory and gastrointestinal tracts, liver, pancreas, thyroid, prostate, and bladder lineages), mesodermal (adipogenic, osteogenic, and chondrogenic lineages) and ectodermal (skin and neural lineages) (Yamada et al., 2019). In addition, DPSCs were shown to differentiate into myocytes, cardiomyocytes, hepatocyte-like cells, melanocytes, and active neurons (Figure 1C; Stevens et al., 2008; Patil et al., 2014). As a thumb rule, a substantial improvement in the efficacy DPSCs differentiation was observed using defined conditioned media.
Several recent reviews have documented the current knowledge and understanding of DPSCs’ differentiation into vital lineages including their angiogenic and neurogenic potential (Ratajczak et al., 2016; Mortada et al., 2018; Mattei et al., 2021), odontogenic and chondrogenic potential (Nuti et al., 2016; Ching et al., 2017; Mortada and Mortada, 2018), and periodontal and dental tissue regeneration (Hu et al., 2018; Zhai et al., 2019); Therefore, we will focus in this section in summarizing the current knowledge regarding DPSCs hepatogenic and pancreatic β-cells differentiation capacities.
Differentiation of Dental Pulp Stem Cells Into Hepatocytes
Implementing defined, serum-free, and stepwise differentiation protocols that mimic the developmental stages of hepatocytes during embryogenesis were found to be sufficient for inducing hepatogenesis (summarized in Table 2). Using this approach, Ishkitiev et al. (2010) were the pioneers to demonstrate the hepatogenic differentiation potential of DPSCs. Initially, they developed the Ishkitiev et al. (2010) developed the two-stage conditioned media that contained low percentage of fetal bovine serum (FBS) but was enriched with essential hepatogenic inducers (see Table 2). Later, they used a serum-free conditioned medium to generate the hepatocyte-like cells from a CD117+ DPSCs subpopulation (Ishkitiev et al., 2012). The latter hepatogenesis protocol utilized three developmental stages, i.e., cell specification, differentiation, and maturation to generate cells with phenotypical, and functional characteristics similar to hepatocytes. This approach was further improved and implemented in later studies (Table 2; Ferro et al., 2012a; Kumar et al., 2017). Recently, we implemented a similar approach to differentiate a pluripotent-like subpopulation of DPSCs into hepatocyte-like cells with detailed characterization of each differentiation stage and associated markers (Gil-Recio et al., 2020).
TABLE 2
| Differentiation | Inducers | Confirmation markers and tests | Protocol timeline (days) | References |
| Hepatogenesis | • Specification: 2%FBS, HGF • Maturation: ITS-X, dex, and OSM | α-fetoprotein, albumin, hepatic HNF-4, IGF-1, glycogen storage, carbamoyl phosphate synthetase, glucagon, and urea secretion | 22–28 | Ishkitiev et al., 2010 |
| • Specification: ITS-X and embryo-trophic factor • Differentiation: ITS-X, embryo-trophic factor, and HGF • Maturation: ITS-X, embryo-trophic factor, HGF, dex, and OSM | α-fetoprotein, albumin, hepatic HNF-4, IGF-1 gene expression. Glycogen storage. Carbamoyl phosphate synthetase, glucagon, and urea secretion | 22–28 | Ishkitiev et al., 2012 | |
| 1% FCS; HGF, oncostatin, nicotinamide, LDL, FGF-4, insulin, glucose, and linoleic acid | Mdr-1, cyp-2e1, Erythropoietin, cytokeratin 8, cytokeratin 18, and cytokeratin 19 gene expression. Albumin secretion | 40 | Ferro et al., 2012 | |
| • Specification: HGF, EGF, and dex • Maturation: ITS, OSM, and dex | Albumin, TAT, and α-fetoprotein secretion | 28 | Kumar et al., 2017 | |
| • Definitive endoderm generation: KOSR and Act A • Specification: KOSR, FGF-4, and HGF • Differentiation: FGF-4, HGF, OSM, and dex | AAT, G6P, HNF6, and cytokeratin 18 gene expression. CYP3A4 activity and AST activity. Albumin secretion and Glucagon storage | 22 | Gil-Recio et al., 2020 | |
| Pancreatic β-cell like | • Induction: ITS, Act A, sodium butyrate, and β-ME • Differentiation: ITS, taurine, GLP-1, nicotinamide, and NEAAs | C-peptide, Pdx-1, Pax4, Pax6, Ngn3, and Isl-1 gene expression. Insulin and c-peptide secretion | 10 | Govindasamy et al., 2011; Sawangmake et al., 2014; Kanafi et al., 2013; Matei et al., 2017; Yagi Mendoza et al., 2018 |
| • Pre-induction: FBS, RA, and β-ME • Induction: nicotinamide, RA, and β-ME. Alternation between L-DMEM and H-DMEM media, each supplemented with FBS, NNAA, zinc sulfate, and selenium | PDX-1, insulin and GLUT-2 gene expression. Dithizone staining. Insulin secretion | 21 | Carnevale et al., 2013 | |
| • Induction: HGF and αFGF • Differentiation: HGF, αFGF, EGF, and β-ME. Maturation: HGF, nicotinamide, and embryo-trophic factor | Generation of pancreatic -a, -b, -d, and pancreatic polypeptide-producing cells. Expression of Pdx-1Hhex, Mnx1, Neurog3, Pax4, Pax6, Nkx6-1, Ins, GLG, PPY, SST, Glut-2 and AMY2A, and insulin | 17 | Ishkitiev et al., 2013 | |
| Matrigel (3D biomaterial matrix) • Stage 1: Act A, Noggin, LiCl, polyvinyl chloride, and β-ME • Stage 2: retinoic acid, A83-01, LDE225, A83-01, and polyvinyl chloride • Stage 3: polyvinyl chloride, ITS, SB, nicotinamide, and NNAAs | Gene expression for FOXA1, Sox17, glucagon, Pax4, Insulin, Nkx6-1, Neurog3, NeuroD1, Pdx1, and CXCR4. Immunohistochemistry for Nkx6-1, Pdx-1, CXCR4, Sox17, and insulin | Not mentioned | Xu et al., 2019 |
Protocols and composition of media used by different studies to generate hepatocytes and insulin producing pancreatic β-cells from DPSCs.
Differentiation of Dental Pulp Stem Cells Into Pancreatic Insulin-Producing Cells
There are several reports (summarized in Table 2) describing the differentiation of DPSCs into glucose-responsive pancreatic insulin-producing β-cells (IPCs). Using a three-step differentiation procedure, IPCs induction and functionality were confirmed by insulin secretion and C-peptide expression in a glucose-dependent manner (Table 2; Govindasamy et al., 2011; Carnevale et al., 2013; Sawangmake et al., 2014). Interestingly, another study demonstrated that DPSCs-derived IPCs were physiologically functional and, as expected, reversed hyperglycemia to the normal level in streptozotocin (STZ)-induced diabetic mice (Kanafi et al., 2013). Furthermore, Matei et al. (2017) observed that hydrogen sulfide exposure increases insulin and C-peptide secretions, protects against glucotoxicity, and enhances the expression insulin and PI3K/AKT pathway. As a proof of principle, Ishkitiev et al. (2013) confirmed that CD117+ DPSCs subpopulation generated a heterogeneous population of cells that expressed pancreatic-specific endocrine and exocrine markers (Table 2). Notably, comparative studies between 2D and 3D culture systems revealed that IPCs in 3D models mimic in vivo cell growth and possess phenotypical structures like native pancreatic islets (Yagi Mendoza et al., 2018; Xu et al., 2019). Importantly, Xu et al. (2020) documented that coating IPCs with Matrigel, a basement membrane matrix, improves cell survival after orthotopic injection into the pancreatic parenchyma of Sprague Dawley (SD) rats (Table 3).
TABLE 3
| Cell Types | Stimuli | Methods | Outcomes | References |
| T-lymphocytes were isolated from peripheral blood of healthy donors | PHA | Co-culture | Suppression of activated T-cell | Pierdomenico et al., 2005 |
| CD4+-Tbet+(Th1) and CD4+-Gata3+(Th2) | PHA | Co-culture | Suppression of IFN-γ and reduction of IL-4 | Ozdemir et al., 2016 |
| CD4+-Stat3+ (Th17) and CD4+-CD25+-FoxP3+(Treg) | Stimulated, IL-17 increases | |||
| CD4+ CD25+ FoxP3+ T cells | No effect, induction of TGFb1 andIL-10 | |||
| PBMNC | Con A or MLR | Co-culture | Proliferation inhibition and cell cycle arrest at G0 | Wada et al., 2009 |
| IFN-γ pre-treated DPSCs conditioned medium | Trans-well, conditioned media (CM) pretreatment with INF-γ | |||
| CD3 T cells | PHA or MLR | Co-culture Transwell | • Proliferation inhibition and apoptosis induction • Inhibition of IL-2, IL-6, IL-12, IFN-γ, and TNF-α • Induction of anti-inflammatory CD4 CD25 Foxp3, and CXCL10 | Demircan et al., 2011 |
| CD8+ T lymphocytes, B lymphocytes | PHA or MLR. Antibodies against CD3 and CD28 | Co-culture Transwell | • Allogeneic proliferation inhibition • Inhibition of PBMCs response to stimuli • Abrogation of IgM and IgG production by allogeneic B cells | Kwack et al., 2017 |
| THP-1 cells differentiated into macrophages | LPS, nigericin | Co-culture Transwell | • Abrogation of LPS-stimulated secretion of TNF-α but not IL1B • Increase in IDO protein expression • Decrease in p-NFκB-p65 (ser486) expression level | Lee et al., 2016 |
Immunomodulatory profile of DPSCs reported in different studies.
Paracrine Activity of Dental Pulp Stem Cells: Secretome and Exosomes
Currently, accumulating evidence indicates that a great deal of therapeutic benefit of primary DPSCs exists in their paracrine activity, that is, the ability to modulate their microenvironment through the release of bioactive molecules. These factors can be released directly into the surrounding microenvironment known as secretome or they can be embedded within the membrane-bound extracellular nanovesicles (∼30–150 nm in diameter), known as exosome (Thery et al., 2002). These factors include cytokines, chemokines, growth factors, angiogenic mediators, hormones, and regulatory nucleic acid molecules (Wei et al., 2020). In general, secretome and exosomes participate in the processes of tissue replenishment, cellular homeostasis, anti-inflammation, immunomodulation, and other functions (Tang et al., 2021).
In relation to tumor tropism, Altanerova et al. (2016) engineered DPSCs to express the fused yeast suicide gene cytosine deaminase::uracil phosphoribosyl transferase (yCD::UPRT), a gene that converts the nontoxic 5-fluorocytosine (5-FC) into the toxic 5-fluoro-20-deoxyuridine-50-monophosphate (5-FdUMP) (Graepler et al., 2005). Exosomes released from these engineered DPSCs were sufficient to integrate human tumor cells transplanted into the brain of rat models and were able to induce apoptosis in the presence of pro-drug 5-FC (Altanerova et al., 2016).
Secretome of DPSCs contains neurotrophic factors (NDNF, NT-3, NGF, and GDNF) and TGF-β, possessing the therapeutic potential for neurodegenerative diseases (de Almeida et al., 2011). In Alzheimer’s disease (AD) cell model, DPSCs’ secretome reduced the amyloid beta (Aβ) peptide-mediated cell cytotoxicity and apoptosis by stimulating the endogenous survival factor Bcl-2 and decreasing the apoptotic regulator Bax (Ahmed Nel et al., 2016). DPSCs secretome promoted proliferation, migration, and survival in Schwann peripheral glial cells (Yamamoto et al., 2016) and SH-SY5Y neuroblastoma cells (Gervois et al., 2017). Furthermore, conditioned media from DPSCs improved neuromuscular junction innervation and motor neuron survival in a mouse model of amyotrophic lateral sclerosis (ALS) (Wang et al., 2019), and promoted the survival of retinal ganglion cells in a rat model for optic nerve injury (Mead et al., 2014).
Dental pulp stem cells secrete angiogenic growth factors including VEGF, bFGF, and PDGF which are sufficient to mediate the formation of a network of tubular structures of endothelial cells, an indicator of angiogenic stimulation (Zhou H. et al., 2020). Furthermore, conditioned media from cultured DPSCs promoted wound healing, angiogenesis and soft-tissue regeneration in a mouse model of excisional wound healing (Yang et al., 2013).
Taken together, DPSCs secretome and exosome are rich in trophic factors that can mediate tissue regeneration and proliferation, which could be highly useful for prospective cell-free regenerative medicine and advantageous over interventions involving cell transplantation (Vizoso et al., 2017). Nevertheless, a proper characterization of the DPSCs’ secretome and exosome is required since they are significantly influenced by culture conditions (Chin et al., 2021), hypoxia (Aranha et al., 2010), insult (Mattei et al., 2021), DPSCs passage (Faruqu et al., 2020), subpopulation (Nakashima et al., 2009), and stage of differentiation (Huang et al., 2016).
Immunomodulatory Properties of Dental Pulp Stem Cells
The crosstalk between DPSCs and immune cell subsets impacts the functioning of both the innate and adaptive immune systems, implying that DPSCs have immunomodulatory properties – an exciting field that needs to be further investigated [best reviewed in Li et al. (2014) and Andrukhov et al. (2019)]. Immunomodulatory phenotype of DPSCs is primarily attributed to in vitro cell culture approaches and conditions, such as enzymatic stimuli, soluble factors secretions, and cell-to-cell contacts. As though, all of these attributes may not precisely mimic the complexity of the in vivo microenvironment, nevertheless, the data generated are valid, at least in part, with respect to the studied immune cell subsets.
Co-culture cell models have revealed that DPSCs mediate G0/G1 cell cycle arrest of the chemically-activated T cells (Table 3; Pierdomenico et al., 2005); while, other studies also show induction of differential T-cell subset responses. Co-cultures of DPSCs with CD3+, CD4+, or CD8+ T cells mediated differential proliferation arrest, apoptosis and/or induction of regulatory T cells (Treg) (Table 3; Demircan et al., 2011; Zhao et al., 2012; Ozdemir et al., 2016; Kwack et al., 2017). Interestingly, proliferation inhibition of the peripheral blood mononuclear cells (PBMCs) was observed in cultures with conditioned medium from DPSCs pre-treated with interferon (INF)-γ (Wada et al., 2009). Taken together, T lymphocyte activation and INF-γ production is a prerequisite for the induction of immunomodulatory DPSCs and secretion of IL-10/TGF-β1, expression of soluble factors inducing Treg formation and lymphocytes proliferation arrest (Ding et al., 2015; Kwack et al., 2017). Furthermore, co-culture of the DPSCs isolated from symptomatic irreversible pulpitis with macrophages suppresses the LPS-stimulated secretion of TNF-α, via TNF-α/IDO (indoleamine 2,3-dioxygenase) axis mechanism (Lee et al., 2016). In a rat model of diabetic neuropathy, DPSCs transplantation led to the anti-inflammatory M2-type macrophage polarization and ameliorated diabetic polyneuropathy (Omi et al., 2016). In addition, DPSCs were reported to express the complement cascade receptors C3aR and C5aR, and the treatment with C3a or C5a augmented DPSCs’ proliferation and mobilization (Chmilewsky et al., 2014; Rufas et al., 2016).
Pre-Clinical and Clinical Applications of Human Dental Pulp Stem Cells
Dental pulp stem cells have remarkable potential as alternative sources to multipotent MSCs and due mainly to their immunomodulatory properties as discussed earlier, DPSCs constitute a highly valuable source for cell therapy of a variety of inflammatory diseases and other disorders. Briefly, in regard to basic or pre-clinical studies in experimental animal models, the human DPSCs-based therapies, implicating cells or secretome/conditioned media, have been successfully used in several disease conditions, which has been extensively reviewed by Anitua et al. (2018) including diabetes (Govindasamy et al., 2011; Datta et al., 2017), neuropathy (Makino et al., 2019), hepatic diseases (Cho et al., 2015; Kim et al., 2016), oculopathies (Syed-Picard et al., 2015; Kushnerev et al., 2016; Mead et al., 2016), spinal cord injury (Sakai et al., 2012; Yang et al., 2017), peripheral nerve injury (Sasaki et al., 2011; Sanen et al., 2017), AD (Nakashima et al., 2009; Mita et al., 2015; Wang et al., 2017), cerebral ischemia (Leong et al., 2012; Song et al., 2017), muscular dystrophy (Kerkis et al., 2008; Pisciotta et al., 2015; Martinez-Sarra et al., 2017), myocardial infarction (Gandia et al., 2008), Parkinson’s disease (Nesti et al., 2011; Gnanasegaran et al., 2017a,b), lung injury (Wakayama et al., 2015), and stroke (Yang et al., 2009; Leong et al., 2012; Song et al., 2015). It is noteworthy that not many clinical trials have so far published their results. Table 4 summarizes the clinical investigations that have ingeniously tested the regenerative potentials and multifaceted benefits of human DPSCs in various trials.
TABLE 4
| Study type | Description/approach | Methods & outcome | References |
| Pre-clinical comparative study using a canine bone defect model | Comparative study aimed to investigate the cell-based bone engineering efficacy and determined the association between the osseointegration of dental implants and tissue-engineered bone by using DPSC, BM-MSC, and periosteal cells (PC) | All premolars and the first molar were extracted from 3 dogs. In each animal, 6 bone defects, 3 on either side, were created after 4 weeks. Different materials were implanted in the defects and allowed to heal. Dental implants were placed in the defects after 8 weeks. After 8 more weeks, bone regeneration was assessed by histology and histomorphometry. It was concluded that DPSC had the highest osteogenic potential compared to BMSC and PC, proving them as a valuable cell source for tissue-engineered bone around dental implants | Ito et al., 2011; Martens et al., 2014 |
| Clinical study investigating bone regeneration effects | Bone regeneration capacity, comparative study between DPSCs, DTSC and BM-MSCs, on hydroxyapatite-coated osseointegrated dental implants, by using tissue engineering technology | In vitro, human DPSCs and DTSCs expressed osteogenic marker genes including alkaline phosphatase, Runx2, and osteocalcin. In vivo, the prepared bone defect model was implanted with graft materials. After 8 weeks, the dental implants were installed and after 16 weeks, sections were assessed histologically and histometrically, confirming the presence of well-formed mature bone and neovascularization. Stem cells with platelet-rich plasma (PRP) can generate bone which might be useful for osseointegrated hydroxyapatite-coated dental implants with improved levels of bone-implant contact | Yamada et al., 2010 |
| Pilot clinical study to assess the safety, efficacy, potential, and feasibility of autologous transplantation of mobilized DPSCs in pulpectomized teeth | Five patients with irreversible pulpitis were enrolled and followed up for up to 24 weeks after mobilized DPSC transplantation | Mobilized DPSCs were procured from discarded teeth and then expanded. The quality of mobilized DPSCs at 9 or 10 passages was assessed by karyotyping. Mobilized DPSCs were transplanted with GCSF in atelocollagen into pulpectomized teeth. No adverse events or toxicity was observed. The cone beam computed tomography confirmed functional dentin formation in 3/5 patients. This study concluded that human mobilized DPSCs were safe and efficacious for total pulp regeneration in endodontics in humans | Nakashima et al., 2017; Karaoz et al., 2011; Mikami et al., 2011 |
| A clinical study using a biocomplex constructed from DPSCs and a collagen sponge scaffold for oro-maxillo-facial (OMF) bone tissue repair in patients requiring extraction of their third molars | This study involved the patients with bilateral bone resorption of the alveolar ridge distal to the 2nd molar, secondary to impaction of the 3rd molar on the cortical alveolar lamina. Since this clinical condition does not permit spontaneous bone repair after extraction of the third molar, it eventually leads to loss of the adjacent 2nd molar as well | DPSCs were isolated from the extracted maxillary 3rd molars and the cells were seeded onto a collagen sponge scaffold. DPSC/collagen sponge biocomplex was used to fill in the injury site. After 3 months of the autologous DPSCs grafting, alveolar bone showed optimal vertical repair and complete restoration of periodontal tissue. Histology revealed the complete bone regeneration, with optimal results after 1 year of autologous DPSCs grafting, indicating that these cells could be used for the repair and regeneration of tissues and organs | D’Aquino et al., 2009; de Almeida et al., 2014 |
| Clinical study evaluating the biological and clinical implications at 3 years following the DPSC-based transplants in human mandibles | This study investigated the stability and quality of the regenerated bone and vascularization after 3 years of the grafting intervention | The authors used conventional procedures, in-line holotomography, and advanced phase-imaging method using synchrotron radiation for increased sensitivity toward low-absorbing structures. It was observed that the regenerated tissue from the graft sites comprised of a fully compact bone with a higher matrix density than control human alveolar spongy bone from the same patient. Although the regenerated bone was not of the proper type found in the mandible, it had a positive clinical impact in terms of increased implant stability as well as improved resistance to physical, chemical, mechanical and pharmacological agents | Giuliani et al., 2013 |
| A 1-year follow-up case series that explored the potential clinical benefits of the DPSCs’ in the regenerative treatment of deep intra-bony defects | In 11 chronic periodontitis patients, a total of 11 isolated intra-bony defects were accessed with a minimally invasive flap and were filled with autologous DPSCs, seeded on a collagen sponge | At 1 year of autologous DPSCs implants, an average clinical attachment level gain of 4.7 ± 1.5 mm, associated with a residual mean probing depth (PD) of 3.2 ± 0.9 mm and remarkable stability of the gingival margin was attained. In 63.6% of the experimental sites, complete pocket closure (PD < 3 mm) was achieved. The clinical outcomes, as supported by the radiographic analysis, showed a bone fill of 3.6 ± 1.9 mm | Aimetti et al., 2018 |
| A single center, two arm ratio 1:1, triple blinded, randomized, placebo-controlled, parallel group, clinical trial (phase I/II study) | The study enrolls 20 serious COVID-19 cases (18–65 years), diagnosed with severe pneumonia: nucleic acid test SARS-CoV-2 positive; respiratory distress (respiratory rate > 30 times per min); hypoxia (resting oxygen saturation < 93% or arterial partial pressure of oxygen/oxygen concentration < 300 mmHg); and typical lung lesions confirmed in chest X-ray image | Both the experimental and control groups receive necessary routine treatment for COVID-19. The experimental group receives the human DPSCs suspension intravenously (3.0 × 107 cells in 30 mL saline solution) on days 1, 4, and 7; while the control group receives an equal amount of saline only (placebo) in parallel. Clinical and laboratory observations (blood tests, liver and kidney functions, inflammatory markers, and immunological tests) to be performed during a period of 28 days for each individual. The primary outcome is time to clinical improvement, i.e., the time (days) it takes to downgrade two levels from the following six ordered grades: Grade 1 – discharge and Grade 6 – death | Ye et al., 2020 |
| Interventional clinical trial of DPSCs (Single group assignment model) | Recruits’ adults/older adults (18–75 years). The experimental arm receives the MSC infusions at days 1, 3, and 7. The interventional or treatment arms receives the DPSCs infusions at days 1, 3, and 7 | Primary outcome measure includes the disappear time (calculated by Kaplan-Meier method) of ground-glass shadow in the lungs (time frame: 14 days). Secondary outcome measures include: (1) Lung shadow absorption (Kaplan-Meier method) by CT scan-chest (time frame: 7, 14, 28, and 360 days; (2) Changes of blood oxygen (blood oxygen values compared by t-test) (time frame: 3, 7, and 14 days | Not yet recruiting. NCT04302519. https://clinicaltrials.gov/ct2/show/NCT04302519 |
| A case report | One patient underwent sinus lift elevation with DPSCs micro-grafts gentle poured onto collagen sponge | A CT scan control was performed after 4 months and DICOM data were processed with medical imaging software to extract the bone density. Pearson’s Chi-square test was used to investigate difference in bone density between native and the newly formed bone. Bone density in newly formed bone was about twice of native bone, indicating that micro-grafts derived from DPSCs poured onto collagen sponge were a useful method for bone regeneration in atrophic maxilla | Brunelli et al., 2013 |
| A case report | This study assessed the clinical and radiographic regenerative potential of autologous DPSCs in treating human non-contained intraosseous defects | A chronic periodontitis patient requiring extraction of the 3rd molar underwent surgery for extraction of the affected molar. Autologous DPSCs were used to regenerate the infra-bony defect on the mandibular right second premolar. At 1-year follow-up examination, the defect was completely filled with bonelike tissue as confirmed by the reentry procedure | Aimetti et al., 2014 |
| A randomized controlled clinical trial | This study evaluated whether the DPSCs delivered into intra-bony defects in a collagen scaffold would ameliorate the clinical and radiographic parameters of periodontal regeneration | Twenty-nine chronic periodontitis patients requiring extraction of one vital tooth were consecutively enrolled. Defects were randomly assigned to test (autologous DPSCs micrografts seeded onto collagen sponge) or control treatments (collagen sponge alone). Clinical and radiographic parameters were recorded at baseline, 6 and 12 months postoperatively. This study concluded that the application of DPSCs significantly improved clinical parameters of periodontal regeneration at 1 year post-treatment | Ferrarotti et al., 2018 |
| A case report | This clinical trial reports the preliminary findings in a patient with periodontal disease who was successfully grafted with allogeneic DPSCs | DPSCs were passaged and cultured without supplementation and 5 × 106 allogeneic DPSCs in 250 μL PBS were seeded onto a dry scaffold of lyophilized collagen-polyvinylpyrrolidone sponge placed in the left lower premolar area of a 61-year-old patient with periodontal disease. At 3- and 6-months follow-ups, there was no sign of rejection, with reduced tooth mobility, periodontal pocket depth and bone defect area but increased bone mineral density at the graft site, suggesting that DPSCs allograft was a promising treatment for correcting bone defects induced by periodontal disease | Hernández-Monjaraz et al., 2018 |
| A single-center, double-blind, randomized, split-mouth, controlled clinical trial | This clinical trial of 32 patients tested the efficacy of autologous DPSCs delivered in a collagen matrix for post-extraction socket healing | Both impacted mandibular 3rd molars were extracted and resulting DPSCs seeded on a resorbable collagen matrix were implanted in 32 experimental post-extraction sockets, whereas collagen matrices alone were implanted in 32 contralateral control post-extraction sockets. At 6 months post-extraction, CT and an advanced display platform was used to record extraction socket density and compared with measurements obtained immediately after extraction. However, the investigators were unable to show that autologous DPSCs reduce socket bone resorption after inferior 3rd molar extraction | Barbier et al., 2018 |
Pre-clinical/clinical studies involving use of human DPSCs.
Of note, owing to their anti-inflammatory properties and regenerative potentials, DPSCs are also being tested for their therapeutic benefits in coronavirus disease 2019 (COVID-19) patients. Like in acute respiratory distress syndrome (ARDS), COVID-19 patients show loss of alveolar structures and invasion/accumulation of proinflammatory M1 macrophages, resulting in the release of proinflammatory cytokines/mediators and enhanced tissue fibrosis. Interestingly, Wakayama et al. (2015) demonstrated earlier in a mouse model study of acute lung injury that intravenous infusion of DPSC/SHED or the conditioned media potentiated the anti-inflammatory effects via M2 macrophage activation and ameliorated the disease pathophysiology. Currently, few clinical trials are in progress to test out the safety and efficacy of DPSCs-based therapies in COVID-19 patients (Table 4).
Concluding Remarks and Future Prospectives
Dental pulp is a promising source of DPSCs, which are multipotent stem cells with potentials of self-renewal, multilineage differentiation, and immunomodulatory functions. These stem cells offer the advantage of more comprehensive clinical applications as compared to MSCs derived from other sources like the peripheral blood, adipose tissue, umbilical cord, and bone marrow. Other intriguing aspects that make the use of DPSCs more attractive is their easy access from the discarded third molar tooth and the minimal ethical concerns are involved in the procurement process, as well as the fact that cryopreserved DPSCs will retain their ability for multilineage differentiation into osteogenic, chondrogenic, dentinogenic, myogenic, neurogenic, and adipogenic lineages. Not surprisingly, DPSCs-based stem cell therapy approaches are currently being exhaustively investigated.
However, it is noteworthy that dental pulp has the element of heterogeneity involved as it is a mixture of different cell types that can differentiate into multiple lineages. Of note, first, dental pulp-derived single-cell suspensions need to be cultured to allow the development of individual clones. Next, individual clones are isolated and single cell types are enriched by extended culture expansion, followed by immunophenotyping to characterize the subpopulations based on molecular and phenotypic markers that regulate their differentiation potential into multiple lineages using either 2- or 3-dimension culture conditions in defined media which promote the desired cell lineage specification (Al Madhoun et al., 2016, 2018). Although, fluorescence-activated cell sorting techniques are applicable and improve single-cell population purity, these approaches have several limitations including the exposure of cells to electric charge which may alter their integrity (Tirino et al., 2011). DPSCs’ capacities to differentiate into various lineages are driven by donor age, genetics, and epigenetic factors such as growth and differentiation factors and culture settings used (Zhou D. et al., 2020). Indeed, further research toward standardization of DPSCs’ isolation and culture protocols is still needed. There is also a pressing need for identifying the markers that more specifically and consistently represent DPSCs. Moreover, it is speculated that the identification of such markers will facilitate the direct purification techniques which will minimize DPSCs’ exposure to culture conditions needed for their prospective medical applications. Regarding cell-banking aspects, new cryopreservation media and optimized methods may have to be established to maintain the viability and immunobiological characteristics of the DPSCs over long term use. Similarly, further studies will also be required to better understand the molecular mechanisms that regulate interactions between DPSCs and various biomaterials. The studies employing transmission electron microscopy may help characterizing different phenotypes of the heterogeneous progenitor cells that populate dental stem cell niches and a rigorous testing of the endothelial-mesenchymal transformation will be required to assess their potential of replenishing these niches.
Last but not least, DPSCs-related cellular or secretome based therapeutic interventions used in pre-clinical and clinical trials have yielded promising outcomes. However, there is a growing need for conducting more clinical trials to further establish the safety and efficacy of the DPSCs-based interventions as a powerful therapeutic tool and to lead development in regenerative medicine. Not surprisingly, major challenges still remain before the DPSCs-based interventions can be translated into clinical application to patients (Yamada et al., 2019). Nevertheless, innovated procedures have been used to develop immortalized DPSCs such as mutant baculovirus-based piggyBac system (Li et al., 2020), and DPSCs transduction with CDK4R24C (Orimoto et al., 2020), cyclin D1 or telomerase reverse transcriptase (Wilson et al., 2015). Furthermore, CRISPR gene editing technology has been recently applied to study the functional role of genetic variations in patient-derived DPSCs such as the role of TRPV4 polymorphism (c.1855C > T), a gene known to be implicated in metatropic dysplasia disease (Kang et al., 2012; Nonaka et al., 2019). Nonaka et al. (2019) studies revealed that this gain of function mutation is associated with alternations in calcium/NFATc1 signaling pathway, which in turn accelerates chondrogenic and osteogenic differentiation of DPSCs causing the congenital skeletal disease (Han et al., 2020). Taken together, these outstanding approaches highlight the importance of DPSCS as an adult stem cell model for prospective contribution in the future development of treatment strategies for human diseases.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Statements
Author contributions
AA, SS, and RA wrote first draft of the manuscript. DH prepared the figures and tables. DH, MA, and FA-M were involved in discussing, drafting, and editing the manuscript. All authors contributed to the drafting and critical review of the manuscript and approved the final draft.
Funding
This study was funded by Kuwait Foundation for the Advancement of Sciences (KFAS) and Dasman Diabetes Institute (DDI), Grant Number RA-2013-009.
Acknowledgments
The authors would like to thank Kuwait University and Dasman Diabetes Institute for providing the financial support and laboratory space.
Conflict of interest
MA is employed by Biointelligence Technology Systems S.L., Barcelona, Spain. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Abbreviations
- HGF
hepatocyte growth factor
- EGF
epidermal growth factor
- VEGF
vascular endothelial growth factor
- bFGF
basic fibroblast growth factor
- PDGF
platelet-derived growth factor
- dex
dexamethasone
- ITS
insulin-transferrin-selenium
- ITS-X
insulin-transferrin-selenium-ethanolamine
- LDL
low density lipoprotein
- FGF-4
fibroblast growth factor-4
- HNF-4
nuclear factor-4 alpha
- IFG-1
insulin-like growth factor-1
- TAT
tyrosine amino transferase
- KOSR
knock-out serum replacement
- GLP-1
glucagon-like peptide
- NEAAs
non-essential amino acids;.
- PHA
phytohemagglutinin
- MLR
mixed lymphocyte reaction
- LPS
lipopolysaccharide
- PBMC
peripheral blood mononuclear cell
- Mdr-1
multidrug resistance protein-I
- cyp-2e1
cytochrome P450-2E1
- Epo
erythropoietin
- Pdx-1
pancreas/duodenum homeobox protein 1
- Hhex
homeobox protein HEX
- MNX1
motor neuron and pancreas homeobox protein 1
- Pax-4/-6
paired box protein Pax-4 and 6
- NKX6-1
homeobox protein Nkx-6.1
- NDNF
neuron-derived neurotrophic factor
- NT-3
neurotrophin-3
- NGF
beta-nerve growth factor
- GDNF
glial cell line-derived neurotrophic factor
- FoxA1
forkhead box A1
- HNF-3- α
hepatocyte nuclear factor 3-alpha
- FoxA2
forkhead box A2
- HNF-3- β
hepatocyte nuclear factor 3-beta
- GLUT-2
glucose transporter-2
- OSM
oncostatin M
- β-ME
beta-mercaptoethanol
- AMY2A
pancreatic alpha-amylase-PA
- Act A
activin A.
References
1
Abd-ElmeguidA.YuD. C. (2009). Dental pulp neurophysiology: part 1. Clinical and diagnostic implications.J. Can. Dent. Assoc.7555–59.
2
Ahmed NelM.MurakamiM.HiroseY.NakashimaM. (2016). Therapeutic potential of dental pulp stem cell secretome for Alzheimer’s disease treatment: an in vitro study.Stem Cells Int.20168102478. 10.1155/2016/8102478
3
AimettiM.FerrarottiF.CricentiL.MarianiG. M.RomanoF. (2014). Autologous dental pulp stem cells in periodontal regeneration: a case report.Int. J. Periodontics Restorative Dent.34s27–s33.
4
AimettiM.FerrarottiF.GambaM. N.GiraudiM.RomanoF. (2018). Regenerative treatment of periodontal intrabony defects using autologous dental pulp stem cells: a 1-year follow-up case series.Int. J. Periodontics Restorative Dent.38, 51–58.
5
AkpinarG.KasapM.AksoyA.DuruksuG.GacarG.KaraozE. (2014). Phenotypic and proteomic characteristics of human dental pulp derived mesenchymal stem cells from a natal, an exfoliated deciduous, and an impacted third molar tooth.Stem Cells Int.2014457059. 10.1155/2014/457059
6
Al MadhounA.AliH.AlKandariS.AtizadoV. L.AkhterN.Al-MullaF.et al (2016). Defined three-dimensional culture conditions mediate efficient induction of definitive endoderm lineage from human umbilical cord Wharton’s jelly mesenchymal stem cells.Stem Cell Res. Ther.7:165. 10.1186/s13287-016-0426-9
7
Al MadhounA.AlkandariS.AliH.CarrioN.AtariM.BitarM. S.et al (2018). Chemically defined conditions mediate an efficient induction of mesodermal lineage from human umbilical cord- and bone marrow- mesenchymal stem cells and dental pulp pluripotent-like stem cells.Cell Reprogram209–16. 10.1089/cell.2017.0028
8
AlraiesA.AlaidaroosN. Y.WaddingtonR. J.MoseleyR.SloanA. J. (2017). Variation in human dental pulp stem cell ageing profiles reflect contrasting proliferative and regenerative capabilities.BMC Cell Biol.18:12. 10.1186/s12860-017-0128-x
9
AlraiesA.WaddingtonR. J.SloanA. J.MoseleyR. (2020). Evaluation of dental pulp stem cell heterogeneity and behaviour in 3D Type I collagen gels.Biomed. Res. Int.2020:3034727. 10.1155/2020/3034727
10
AltanerovaU.BenejovaK.AltanerovaV.TyciakovaS.RychlyB.SzomolanyiP.et al (2016). Dental pulp mesenchymal stem/stromal cells labeled with iron sucrose release exosomes and cells applied intra-nasally migrate to intracerebral glioblastoma.Neoplasma63925–933. 10.4149/neo_2016_611
11
AndrukhovO.BehmC.BlufsteinA.Rausch-FanX. (2019). Immunomodulatory properties of dental tissue-derived mesenchymal stem cells: implication in disease and tissue regeneration.World J. Stem Cells11604–617. 10.4252/wjsc.v11.i9.604
12
AnituaE.TroyaM.ZalduendoM. (2018). Progress in the use of dental pulp stem cells in regenerative medicine.Cytotherapy20479–498. 10.1016/j.jcyt.2017.12.011
13
AranhaA. M.ZhangZ.NeivaK. G.CostaC. A.HeblingJ.NorJ. E. (2010). Hypoxia enhances the angiogenic potential of human dental pulp cells.J. Endod.361633–1637. 10.1016/j.joen.2010.05.013
14
AtariM.BarajasM.Hernandez-AlfaroF.GilC.FabregatM.Ferres PadroE.et al (2011). Isolation of pluripotent stem cells from human third molar dental pulp.Histol. Histopathol.261057–1070.
15
AtariM.Gil-RecioC.FabregatM.Garcia-FernandezD.BarajasM.CarrascoM. A.et al (2012). Dental pulp of the third molar: a new source of pluripotent-like stem cells.J. Cell Sci.1253343–3356. 10.1242/jcs.096537
16
BakopoulouA.KritisA.AndreadisD.PapachristouE.LeyhausenG.KoidisP.et al (2015). Angiogenic potential and secretome of human apical papilla mesenchymal stem cells in various stress microenvironments.Stem Cells Dev.242496–2512. 10.1089/scd.2015.0197
17
BalliniA.CantoreS.ScaccoS.PerilloL.ScaranoA.AityanS. K.et al (2019). A comparative study on different stemness gene expression between dental pulp stem cells vs. dental bud stem cells.Eur. Rev. Med. Pharmacol. Sci.231626–1633.
18
BarbierL.RamosE.MendiolaJ.RodriguezO.SantamariaG.SantamariaJ.et al (2018). Autologous dental pulp mesenchymal stem cells for inferior third molar post-extraction socket healing: a split-mouth randomised clinical trial.Med. Oral Patol. Oral Cir. Bucal23e469–e477. 10.4317/medoral.22466
19
BerkovitzB. K. B. (1989). Teeth.Berlin: Springer-Verlag. 10.1007/978-3-642-83496-7
20
BhandiS.Al KahtaniA.MashyakhyM.AlsofiL.MaganurP. C.VishwanathaiahS.et al (2021). Modulation of the dental pulp stem cell secretory profile by hypoxia induction using cobalt chloride.J. Pers. Med.11:247. 10.3390/jpm11040247
21
BronckaersA.HilkensP.FantonY.StruysT.GervoisP.PolitisC.et al (2013). Angiogenic properties of human dental pulp stem cells.PLoS One8:e71104. 10.1371/journal.pone.0071104
22
BrunelliG.MotroniA.GrazianoA.D’AquinoR.ZollinoI.CarinciF. (2013). Sinus lift tissue engineering using autologous pulp micro-grafts: a case report of bone density evaluation.J. Indian Soc. Periodontol.17, 644–647.
23
CarnevaleG.RiccioM.PisciottaA.BerettiF.MaraldiT.ZavattiM.et al (2013). In vitro differentiation into insulin-producing beta-cells of stem cells isolated from human amniotic fluid and dental pulp.Dig. Liver Dis.45669–676. 10.1016/j.dld.2013.02.007
24
CatonJ.TuckerA. S. (2009). Current knowledge of tooth development: patterning and mineralization of the murine dentition.J. Anat.214502–515. 10.1111/j.1469-7580.2008.01014.x
25
ChinY. T.LiuC. M.ChenT. Y.ChungY. Y.LinC. Y.HsiungC. N.et al (2021). 2,3,5,4’-tetrahydroxystilbene-2-O-beta-D-glucoside-stimulated dental pulp stem cells-derived conditioned medium enhances cell activity and anti-inflammation.J. Dent. Sci.16586–598. 10.1016/j.jds.2020.10.014
26
ChingH. S.LuddinN.IRahmanA.PonnurajK. T. (2017). Expression of odontogenic and osteogenic markers in DPSCs and SHED: a review.Curr. Stem Cell Res. Ther.1271–79. 10.2174/1574888X11666160815095733
27
ChmilewskyF.JeanneauC.LaurentP.AboutI. (2014). Pulp fibroblasts synthesize functional complement proteins involved in initiating dentin-pulp regeneration.Am. J. Pathol.1841991–2000. 10.1016/j.ajpath.2014.04.003
28
ChoY. A.NohK.JueS. S.LeeS. Y.KimE. C. (2015). Melatonin promotes hepatic differentiation of human dental pulp stem cells: clinical implications for the prevention of liver fibrosis.J. Pineal Res.58127–135. 10.1111/jpi.12198
29
D’AquinoR.De RosaA.LanzaV.TirinoV.LainoL.GrazianoA.et al (2009). Human mandible bone defect repair by the grafting of dental pulp stem/progenitor cells and collagen sponge biocomplexes.Eur. Cells Mater.18, 75–83.
30
DattaI.BhadriN.ShahaniP.MajumdarD.SowmithraS.RazdanR.et al (2017). Functional recovery upon human dental pulp stem cell transplantation in a diabetic neuropathy rat model.Cytotherapy191208–1224. 10.1016/j.jcyt.2017.07.009
31
de AlmeidaF. M.MarquesS. A.Ramalho BdosS.RodriguesR. F.CadilheD. V.FurtadoD.et al (2011). Human dental pulp cells: a new source of cell therapy in a mouse model of compressive spinal cord injury.J. Neurotrauma281939–1949. 10.1089/neu.2010.1317
32
de AlmeidaJ. F.ChenP.HenryM. A.DiogenesA. (2014). Stem cells of the apical papilla regulate trigeminal neurite outgrowth and targeting through a BDNF-dependent mechanism.Tissue Eng. Part A203089–3100. 10.1089/ten.tea.2013.0347
33
DemircanP. C.SariboyaciA. E.UnalZ. S.GacarG.SubasiC.KaraozE. (2011). Immunoregulatory effects of human dental pulp-derived stem cells on T cells: comparison of transwell co-culture and mixed lymphocyte reaction systems.Cytotherapy131205–1220. 10.3109/14653249.2011.605351
34
DengZ.YanW.DaiX.ChenM.QuQ.WuB.et al (2021). N-cadherin regulates the odontogenic differentiation of dental pulp stem cells via beta-catenin activity.Front. Cell Dev. Biol.9:661116. 10.3389/fcell.2021.661116
35
DingG.NiuJ.LiuY. (2015). Dental pulp stem cells suppress the proliferation of lymphocytes via transforming growth factor-beta1.Hum. Cell2881–90. 10.1007/s13577-014-0106-y
36
DominiciM.Le BlancK.MuellerI.Slaper-CortenbachI.MariniF.KrauseD.et al (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement.Cytotherapy8315–317. 10.1080/14653240600855905
37
FargesJ. C.Alliot-LichtB.RenardE.DucretM.GaudinA.SmithA. J.et al (2015). Dental pulp defence and repair mechanisms in dental caries.Med. Inflamm.2015:230251. 10.1155/2015/230251
38
FaruquF. N.ZhouS.SamiN.GheidariF.LuH.Al-JamalK. T. (2020). Three-dimensional culture of dental pulp pluripotent-like stem cells (DPPSCs) enhances Nanog expression and provides a serum-free condition for exosome isolation.FASEB Bioadv.2419–433. 10.1096/fba.2020-00025
39
FengJ.MantessoA.De BariC.NishiyamaA.SharpeP. T. (2011). Dual origin of mesenchymal stem cells contributing to organ growth and repair.Proc. Natl. Acad. Sci. U.S.A.1086503–6508. 10.1073/pnas.1015449108
40
FerrarottiF.RomanoF.GambaM. N.QuiricoA.GiraudiM.AudagnaM.et al (2018). Human intrabony defect regeneration with micrografts containing dental pulp stem cells: a randomized controlled clinical trial.J. Clin. Periodontol.45, 841–850.
41
FerroF.SpelatR.BeltramiA. P.CesselliD.CurcioF. (2012a). Isolation and characterization of human dental pulp derived stem cells by using media containing low human serum percentage as clinical grade substitutes for bovine serum.PLoS One7:e48945. 10.1371/journal.pone.0048945
42
FerroF.SpelatR.D’AurizioF.PuppatoE.PandolfiM.BeltramiA. P.et al (2012b). Dental pulp stem cells differentiation reveals new insights in Oct4A dynamics.PLoS One7:e41774. 10.1371/journal.pone.0041774
43
GandiaC.ArminanA.Garcia-VerdugoJ. M.LledoE.RuizA.MinanaM. D.et al (2008). Human dental pulp stem cells improve left ventricular function, induce angiogenesis, and reduce infarct size in rats with acute myocardial infarction.Stem Cells26638–645. 10.1634/stemcells.2007-0484
44
GervoisP.WolfsE.DillenY.HilkensP.RatajczakJ.DriesenR. B.et al (2017). Paracrine maturation and migration of SH-SY5Y cells by dental pulp stem cells.J. Dent. Res.96654–662. 10.1177/0022034517690491
45
GhannamM. G.AlameddineH.BordoniB. (2021). Anatomy, Head and Neck, Pulp (Tooth).Treasure Island, FL: StatPearls.
46
Gil-RecioC.MontoriS.VallejoC.DemourS. A.Ferrés-PadróE.BarajasM.et al (2020). Direct differentiation of dental pulp pluripotent-like stem cells differentiation into hepatocyte-like Cells.bioRxiv [Preprint]bioRxiv: 2020.12.09.418780, 10.1101/2020.12.09.418780
47
GiulianiN.LisignoliG.MagnaniM.RacanoC.BolzoniM.Dalla PalmaB.et al (2013). New insights into osteogenic and chondrogenic differentiation of human bone marrow mesenchymal stem cells and their potential clinical applications for bone regeneration in pediatric orthopaedics.Stem Cells Int.2013:312501.
48
GnanasegaranN.GovindasamyV.ManiV.Abu KasimN. H. (2017a). Neuroimmunomodulatory properties of DPSCs in an in vitro model of Parkinson’s disease.IUBMB Life69689–699. 10.1002/iub.1655
49
GnanasegaranN.GovindasamyV.SimonC.GanQ. F.Vincent-ChongV. K.ManiV.et al (2017b). Effect of dental pulp stem cells in MPTP-induced old-aged mice model.Eur. J. Clin. Invest.47403–414. 10.1111/eci.12753
50
GotjamanosT. (1969). Cellular organization in the subodontoblastic zone of the dental pulp. I. A study of cell-free and cell-rich layers in pulps of adult rat and deciduous monkey teeth.Arch. Oral. Biol.141007–1010. 10.1016/0003-9969(69)90070-3
51
GovindasamyV.AbdullahA. N.RonaldV. S.MusaS.Ab AzizZ. A.ZainR. B.et al (2010). Inherent differential propensity of dental pulp stem cells derived from human deciduous and permanent teeth.J. Endod.361504–1515. 10.1016/j.joen.2010.05.006
52
GovindasamyV.RonaldV. S.AbdullahA. N.NathanK. R.Ab AzizZ. A.AbdullahM.et al (2011). Differentiation of dental pulp stem cells into islet-like aggregates.J. Dent. Res.90646–652. 10.1177/0022034510396879
53
GraeplerF.LemkenM. L.WybranietzW. A.SchmidtU.SmirnowI.GrossC. D.et al (2005). Bifunctional chimeric SuperCD suicide gene -YCD: YUPRT fusion is highly effective in a rat hepatoma model.World J. Gastroenterol. WJG116910–6919. 10.3748/wjg.v11.i44.6910
54
GronthosS.MankaniM.BrahimJ.RobeyP. G.ShiS. (2000). Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo.Proc. Natl. Acad. Sci. U.S.A.9713625–13630. 10.1073/pnas.240309797
55
HanM.-J.SeoY.-K.YoonH.-H.SongK.-Y.ParkJ.-K. (2008). Effect of mechanical tension on the human dental pulp cells.Biotechnol. Bioprocess Eng.13410–417. 10.1007/s12257-008-0146-9
56
HanM.-J.SeoY.-K.YoonH.-H.SongK.-Y.ParkJ.-K. (2010). Upregulation of bone-like extracellular matrix expression in human dental pulp stem cells by mechanical strain.Biotechnol. Bioprocess Eng.15572–579. 10.1007/s12257-009-0102-3
57
HanX.KatoH.SatoH.HirofujiY.FukumotoS.MasudaK. (2020). Accelerated osteoblastic differentiation in patient-derived dental pulp stem cells carrying a gain-of-function mutation of TRPV4 associated with metatropic dysplasia.Biochem. Biophys. Res. Commun..523841–846. 10.1016/j.bbrc.2019.12.123
58
HataM.NaruseK.OzawaS.KobayashiY.NakamuraN.KojimaN.et al (2013). Mechanical stretch increases the proliferation while inhibiting the osteogenic differentiation in dental pulp stem cells.Tissue Eng. Part A19625–633. 10.1089/ten.tea.2012.0099
59
Hernández-MonjarazB.Santiago-OsorioE.Ledesma-MartÃnezE.Alcauter-ZavalaA.Mendoza-NúñezV. M. (2018). Retrieval of a periodontally compromised tooth by allogeneic grafting of mesenchymal stem cells from dental pulp: a case report.J. Int. Med. Res.462983–2993. 10.1177/0300060518773244
60
HilkensP.FantonY.MartensW.GervoisP.StruysT.PolitisC.et al (2014). Pro-angiogenic impact of dental stem cells in vitro and in vivo.Stem Cell Res.12778–790. 10.1016/j.scr.2014.03.008
61
HilkensP.GervoisP.FantonY.VanormelingenJ.MartensW.StruysT.et al (2013). Effect of isolation methodology on stem cell properties and multilineage differentiation potential of human dental pulp stem cells.Cell Tissue Res.35365–78. 10.1007/s00441-013-1630-x
62
HosmaniJ.AssiriK.AlmubarakH. M.MannakandathM. L.Al-HakamiA.PatilS.et al (2020). Proteomic profiling of various human dental stem cells – a systematic review.World J. Stem Cells121214–1236. 10.4252/wjsc.v12.i10.1214
63
HosoyaA.YukitaA.YoshibaK.YoshibaN.TakahashiM.NakamuraH. (2012). Two distinct processes of bone-like tissue formation by dental pulp cells after tooth transplantation.J. Histochem. Cytochem.60861–873. 10.1369/0022155412459741
64
HuL.LiuY.WangS. (2018). Stem cell-based tooth and periodontal regeneration.Oral Dis.24696–705. 10.1111/odi.12703
65
HuangC. C.NarayananR.AlapatiS.RavindranS. (2016). Exosomes as biomimetic tools for stem cell differentiation: applications in dental pulp tissue regeneration.Biomaterials111103–115. 10.1016/j.biomaterials.2016.09.029
66
HuangC. E.HuF. W.YuC. H.TsaiL. L.LeeT. H.ChouM. Y.et al (2014). Concurrent expression of Oct4 and Nanog maintains mesenchymal stem-like property of human dental pulp cells.Int. J. Mol. Sci.1518623–18639. 10.3390/ijms151018623
67
HuangG. T.GronthosS.ShiS. (2009). Mesenchymal stem cells derived from dental tissues vs. those from other sources: their biology and role in regenerative medicine.J. Dent. Res.88792–806. 10.1177/0022034509340867
68
IshkitievN.YaegakiK.CalenicB.NakaharaT.IshikawaH.MitievV.et al (2010). Deciduous and permanent dental pulp mesenchymal cells acquire hepatic morphologic and functional features in vitro.J. Endod.36469–474. 10.1016/j.joen.2009.12.022
69
IshkitievN.YaegakiK.ImaiT.TanakaT.NakaharaT.IshikawaH.et al (2012). High-purity hepatic lineage differentiated from dental pulp stem cells in serum-free medium.J. Endod.38475–480. 10.1016/j.joen.2011.12.011
70
IshkitievN.YaegakiK.KozhuharovaA.TanakaT.OkadaM.MitevV.et al (2013). Pancreatic differentiation of human dental pulp CD117(+) stem cells.Regen. Med.8597–612. 10.2217/rme.13.42
71
ItoK.YamadaY.NakamuraS.UedaM. (2011). Osteogenic potential of effective bone engineering using dental pulp stem cells, bone marrow stem cells, and periosteal cells for osseointegration of dental implants.Int. J. Oral Maxillofac. Implants26, 947–954.
72
JoY. Y.LeeH. J.KookS. Y.ChoungH. W.ParkJ. Y.ChungJ. H.et al (2007). Isolation and characterization of postnatal stem cells from human dental tissues.Tissue Eng.13767–773. 10.1089/ten.2006.0192
73
KanafiM. M.RajeshwariY. B.GuptaS.DadheechN.NairP. D.GuptaP. K.et al (2013). Transplantation of islet-like cell clusters derived from human dental pulp stem cells restores normoglycemia in diabetic mice.Cytotherapy151228–1236. 10.1016/j.jcyt.2013.05.008
74
KangS. S.ShinS. H.AuhC. K.ChunJ. (2012). Human skeletal dysplasia caused by a constitutive activated transient receptor potential vanilloid 4 (TRPV4) cation channel mutation.Exp. Mol. Med.44707–722. 10.3858/emm.2012.44.12.080
75
KaraozE.DemircanP. C.SaglamO.AksoyA.KaymazF.DuruksuG. (2011). Human dental pulp stem cells demonstrate better neural and epithelial stem cell properties than bone marrow-derived mesenchymal stem cells.Histochem. Cell Biol.136455–473. 10.1007/s00418-011-0858-3
76
KaukuaN.ShahidiM. K.KonstantinidouC.DyachukV.KauckaM.FurlanA.et al (2014). Glial origin of mesenchymal stem cells in a tooth model system.Nature513551–554. 10.1038/nature13536
77
KawanabeN.MurataS.FukushimaH.IshiharaY.YanagitaT.YanagitaE.et al (2012). Stage-specific embryonic antigen-4 identifies human dental pulp stem cells.Exp. Cell Res.318453–463. 10.1016/j.yexcr.2012.01.008
78
KawashimaN. (2012). Characterisation of dental pulp stem cells: a new horizon for tissue regeneration?Arch. Oral Biol.571439–1458. 10.1016/j.archoralbio.2012.08.010
79
KellnerM.SteindorffM. M.StrempelJ. F.WinkelA.KuhnelM. P.StieschM. (2014). Differences of isolated dental stem cells dependent on donor age and consequences for autologous tooth replacement.Arch. Oral Biol.59559–567. 10.1016/j.archoralbio.2014.02.014
80
KerkisI.AmbrosioC. E.KerkisA.MartinsD. S.ZucconiE.FonsecaS. A.et al (2008). Early transplantation of human immature dental pulp stem cells from baby teeth to golden retriever muscular dystrophy (GRMD) dogs: local or systemic?J. Transl. Med.6:35. 10.1186/1479-5876-6-35
81
KerkisI.KerkisA.DozortsevD.Stukart-ParsonsG. C.Gomes MassironiS. M.PereiraL. V.et al (2006). Isolation and characterization of a population of immature dental pulp stem cells expressing OCT-4 and other embryonic stem cell markers.Cells Tissues Organs.184105–116. 10.1159/000099617
82
KimH. J.ChoY. A.LeeY. M.LeeS. Y.BaeW. J.KimE. C. (2016). PIN1 suppresses the hepatic differentiation of pulp stem cells via wnt3a.J. Dent. Res.951415–1424. 10.1177/0022034516659642
83
KobayashiT.ToriiD.IwataT.IzumiY.NasuM.TsutsuiT. W. (2020). Characterization of proliferation, differentiation potential, and gene expression among clonal cultures of human dental pulp cells.Hum. Cell33490–501. 10.1007/s13577-020-00327-9
84
KoussoulakouD. S.MargaritisL. H.KoussoulakosS. L. (2009). A curriculum vitae of teeth: evolution, generation, regeneration.Int. J. Biol. Sci.5226–243. 10.7150/ijbs.5.226
85
KrivanekJ.AdameykoI.FriedK. (2017). Heterogeneity and developmental connections between cell types inhabiting teeth.Front. Physiol.8:376. 10.3389/fphys.2017.00376
86
KrivanekJ.SoldatovR. A.KastritiM. E.ChontorotzeaT.HerdinaA. N.PetersenJ.et al (2020). Dental cell type atlas reveals stem and differentiated cell types in mouse and human teeth.Nat. Commun.11:4816. 10.1038/s41467-020-18512-7
87
KumarA.KumarV.RattanV.JhaV.PalA.BhattacharyyaS. (2017). Molecular spectrum of secretome regulates the relative hepatogenic potential of mesenchymal stem cells from bone marrow and dental tissue.Sci. Rep.7:15015. 10.1038/s41598-017-14358-0
88
KushnerevE.ShawcrossS. G.SothirachaganS.CarleyF.BrahmaA.YatesJ. M.et al (2016). Regeneration of corneal epithelium with dental pulp stem cells using a contact lens delivery system.Invest. Ophthalmol. Vis. Sci.575192–5199. 10.1167/iovs.15-17953
89
KwackK. H.LeeJ. M.ParkS. H.LeeH. W. (2017). Human dental pulp stem cells suppress alloantigen-induced immunity by stimulating t cells to release transforming growth factor beta.J. Endod.43100–108. 10.1016/j.joen.2016.09.005
90
LainoG.d’AquinoR.GrazianoA.LanzaV.CarinciF.NaroF.et al (2005). A new population of human adult dental pulp stem cells: a useful source of living autologous fibrous bone tissue (LAB).J. Bone Miner. Res.201394–1402. 10.1359/JBMR.050325
91
LeeS.ZhangQ. Z.KarabucakB.LeA. D. (2016). DPSCs from inflamed pulp modulate macrophage function via the TNF-alpha/IDO Axis.J. Dent. Res.951274–1281. 10.1177/0022034516657817
92
LeongW. K.HenshallT. L.ArthurA.KremerK. L.LewisM. D.HelpsS. C.et al (2012). Human adult dental pulp stem cells enhance poststroke functional recovery through non-neural replacement mechanisms.Stem Cells Transl. Med.1177–187. 10.5966/sctm.2011-0039
93
LeprinceJ. G.ZeitlinB. D.TolarM.PetersO. A. (2012). Interactions between immune system and mesenchymal stem cells in dental pulp and periapical tissues.Int. Endod. J.45689–701. 10.1111/j.1365-2591.2012.02028.x
94
LesotH. (2000). Odontoblast differentiation and tooth morphogenesis.J. Dent. Res.791640–1644. 10.1177/00220345000790090101
95
LiX.WangL.SuQ.YeL.ZhouX.SongD.et al (2020). Highly proliferative immortalized human dental pulp cells retain the odontogenic phenotype when combined with a beta-tricalcium phosphate scaffold and BMP2.Stem Cells Int.2020:4534128. 10.1155/2020/4534128
96
LiZ.JiangC. M.AnS.ChengQ.HuangY. F.WangY. T.et al (2014). Immunomodulatory properties of dental tissue-derived mesenchymal stem cells.Oral Dis.2025–34. 10.1111/odi.12086
97
LindroosB.MaenpaaK.YlikomiT.OjaH.SuuronenR.MiettinenS. (2008). Characterisation of human dental stem cells and buccal mucosa fibroblasts.Biochem. Biophys. Res. Commun.368329–335. 10.1016/j.bbrc.2008.01.081
98
LiuJ.JinT. C.ChangS.Czajka-JakubowskaA.ClarksonB. H. (2011). Adhesion and growth of dental pulp stem cells on enamel-like fluorapatite surfaces.J. Biomed. Mater. Res. A96528–534. 10.1002/jbm.a.33002
99
LiuL.LingJ.WeiX.WuL.XiaoY. (2009). Stem cell regulatory gene expression in human adult dental pulp and periodontal ligament cells undergoing odontogenic/osteogenic differentiation.J. Endod.351368–1376. 10.1016/j.joen.2009.07.005
100
LiuL.WeiX.LingJ.WuL.XiaoY. (2011). Expression pattern of Oct-4, Sox2, and c-Myc in the primary culture of human dental pulp derived cells.J. Endod.37466–472. 10.1016/j.joen.2010.12.012
101
LongoniA.UtomoL.Ivan HooijdonkE.BittermannG. K.VetterV. C.Kruijt SpanjerE. C.et al (2020). The chondrogenic differentiation potential of dental pulp stem cells.Eur. Cell Mater.39121–135. 10.22203/eCM.v039a08
102
MagnussonB. (1968). Tissue changes during molar tooth eruption.Trans. R. Sch. Dent. Stockh. Umea131–122.
103
MakinoE.NakamuraN.MiyabeM.ItoM.KanadaS.HataM.et al (2019). Conditioned media from dental pulp stem cells improved diabetic polyneuropathy through anti-inflammatory, neuroprotective and angiogenic actions: cell-free regenerative medicine for diabetic polyneuropathy.J. Diabetes Invest.101199–1208. 10.1111/jdi.13045
104
MarrelliM.CodispotiB.SheltonR. M.SchevenB. A.CooperP. R.TatulloM.et al (2018). Dental pulp stem cell mechanoresponsiveness: effects of mechanical stimuli on dental pulp stem cell behavior.Front. Physiol.9:1685. 10.3389/fphys.2018.01685
105
MartensW.SanenK.GeorgiouM.StruysT.BronckaersA.AmelootM.et al (2014). Human dental pulp stem cells can differentiate into Schwann cells and promote and guide neurite outgrowth in an aligned tissue-engineered collagen construct in vitro.FASEB J.281634–1643. 10.1096/fj.13-243980
106
MartensW.WolfsE.StruysT.PolitisC.BronckaersA.LambrichtsI. (2012). Expression pattern of basal markers in human dental pulp stem cells and tissue.Cells Tissues Organs196490–500. 10.1159/000338654
107
Martinez-SarraE.MontoriS.Gil-RecioC.Nunez-ToldraR.CostamagnaD.RotiniA.et al (2017). Human dental pulp pluripotent-like stem cells promote wound healing and muscle regeneration.Stem Cell Res Ther.8:175. 10.1186/s13287-017-0621-3
108
MateiI. V.IiH.YaegakiK. (2017). Hydrogen sulfide enhances pancreatic beta-cell differentiation from human tooth under normal and glucotoxic conditions.Regen. Med.12125–141. 10.2217/rme-2016-0142
109
MatteiV.MartellucciS.PulciniF.SantilliF.SoriceM.Delle MonacheS. (2021). Regenerative potential of DPSCs and revascularization: direct, paracrine or autocrine effect?Stem Cell Rev. Rep.10.1007/s12015-021-10162-6
110
MeadB.HillL. J.BlanchR. J.WardK.LoganA.BerryM.et al (2016). Mesenchymal stromal cell-mediated neuroprotection and functional preservation of retinal ganglion cells in a rodent model of glaucoma.Cytotherapy18487–496. 10.1016/j.jcyt.2015.12.002
111
MeadB.LoganA.BerryM.LeadbeaterW.SchevenB. A. (2014). Dental pulp stem cells, a paracrine-mediated therapy for the retina.Neural Regen. Res.9577–578. 10.4103/1673-5374.130089
112
MendiA.YagciB. G.KizilogluM.SaracN.YilmazD.UgurA.et al (2017). Effects of Syzygium aromaticum, Cinnamomum zeylanicum, and Salvia triloba extracts on proliferation and differentiation of dental pulp stem cells.J. Appl. Oral Sci.25515–522. 10.1590/1678-7757-2016-0522
113
MikamiY.IshiiY.WatanabeN.ShirakawaT.SuzukiS.IrieS.et al (2011). CD271/p75(NTR) inhibits the differentiation of mesenchymal stem cells into osteogenic, adipogenic, chondrogenic, and myogenic lineages.Stem Cells Dev.20901–913. 10.1089/scd.2010.0299
114
MiletichI.SharpeP. T. (2004). Neural crest contribution to mammalian tooth formation.Birth Defects Res. C Embryo Today72200–212. 10.1002/bdrc.20012
115
MitaT.Furukawa-HibiY.TakeuchiH.HattoriH.YamadaK.HibiH.et al (2015). Conditioned medium from the stem cells of human dental pulp improves cognitive function in a mouse model of Alzheimer’s disease.Behav. Brain Res.293189–197. 10.1016/j.bbr.2015.07.043
116
MitranoT. I.GrobM. S.CarrionF.Nova-LampertiE.LuzP. A.FierroF. S.et al (2010). Culture and characterization of mesenchymal stem cells from human gingival tissue.J. Periodontol.81917–925. 10.1902/jop.2010.090566
117
MitsiadisT. A.FekiA.PapaccioG.CatonJ. (2011). Dental pulp stem cells, niches, and notch signaling in tooth injury.Adv. Dent. Res.23275–279. 10.1177/0022034511405386
118
MiuraM.GronthosS.ZhaoM.LuB.FisherL. W.RobeyP. G.et al (2003). SHED: stem cells from human exfoliated deciduous teeth.Proc. Natl. Acad. Sci. U.S.A1005807–5812. 10.1073/pnas.0937635100
119
MorsczeckC.GotzW.SchierholzJ.ZeilhoferF.KuhnU.MohlC.et al (2005). Isolation of precursor cells (PCs) from human dental follicle of wisdom teeth.Matrix Biol.24155–165. 10.1016/j.matbio.2004.12.004
120
MortadaI.MortadaR. (2018). Dental pulp stem cells and osteogenesis: an update.Cytotechnology701479–1486. 10.1007/s10616-018-0225-5
121
MortadaI.MortadaR.Al BazzalM. (2018). Dental pulp stem cells and neurogenesis.Adv. Exp. Med. Biol.108363–75. 10.1007/5584_2017_71
122
NakashimaM.IoharaK.SugiyamaM. (2009). Human dental pulp stem cells with highly angiogenic and neurogenic potential for possible use in pulp regeneration.Cytokine Growth Factor Rev.20435–440. 10.1016/j.cytogfr.2009.10.012
123
NakashimaM.IoharaK.MurakamiM.NakamuraH.SatoY.ArijiY.et al (2017). Pulp regeneration by transplantation of dental pulp stem cells in pulpitis: a pilot clinical study.Stem Cell Res. Ther.8:61.
124
NestiC.PardiniC.BarachiniS.D’AlessandroD.SicilianoG.MurriL.et al (2011). Human dental pulp stem cells protect mouse dopaminergic neurons against MPP+ or rotenone.Brain Res.136794–102. 10.1016/j.brainres.2010.09.042
125
NiehageC.KarbanovaJ.SteenblockC.CorbeilD.HoflackB. (2016). Cell surface proteome of dental pulp stem cells identified by label-free mass spectrometry.PLoS One11:e0159824. 10.1371/journal.pone.0159824
126
NonakaK.HanX.KatoH.SatoH.YamazaH.HirofujiY.et al (2019). Novel gain-of-function mutation of TRPV4 associated with accelerated chondrogenic differentiation of dental pulp stem cells derived from a patient with metatropic dysplasia.Biochem. Biophys. Rep.19:100648. 10.1016/j.bbrep.2019.100648
127
Nunez-ToldraR.DostaP.MontoriS.RamosV.AtariM.BorrosS. (2017a). Improvement of osteogenesis in dental pulp pluripotent-like stem cells by oligopeptide-modified poly(beta-amino ester)s.Acta Biomater.53152–164. 10.1016/j.actbio.2017.01.077
128
Nunez-ToldraR.Martinez-SarraE.Gil-RecioC.CarrascoM. A.Al MadhounA.MontoriS.et al (2017b). Dental pulp pluripotent-like stem cells (DPPSC), a new stem cell population with chromosomal stability and osteogenic capacity for biomaterials evaluation.BMC Cell Biol.18:21. 10.1186/s12860-017-0137-9
129
NutiN.CoralloC.ChanB. M.FerrariM.Gerami-NainiB. (2016). Multipotent differentiation of human dental pulp stem cells: a literature review.Stem Cell Rev. Rep.12511–523. 10.1007/s12015-016-9661-9
130
OmiM.HataM.NakamuraN.MiyabeM.KobayashiY.KamiyaH.et al (2016). Transplantation of dental pulp stem cells suppressed inflammation in sciatic nerves by promoting macrophage polarization towards anti-inflammation phenotypes and ameliorated diabetic polyneuropathy.J. Diabetes Invest.7485–496. 10.1111/jdi.12452
131
OrimotoA.KyakumotoS.EitsukaT.NakagawaK.KiyonoT.FukudaT. (2020). Efficient immortalization of human dental pulp stem cells with expression of cell cycle regulators with the intact chromosomal condition.PLoS One15:e0229996. 10.1371/journal.pone.0229996
132
OzdemirA. T.Ozgul OzdemirR. B.KirmazC.SariboyaciA. E.Unal HalbutogllariZ. S.OzelC.et al (2016). The paracrine immunomodulatory interactions between the human dental pulp derived mesenchymal stem cells and CD4 T cell subsets.Cell Immunol.310108–115. 10.1016/j.cellimm.2016.08.008
133
PangY. W.FengJ.DaltoeF.FatscherR.GentlemanE.GentlemanM. M.et al (2016). Perivascular stem cells at the tip of mouse incisors regulate tissue regeneration.J. Bone Miner. Res.31514–523. 10.1002/jbmr.2717
134
PatilR.KumarB. M.LeeW. J.JeonR. H.JangS. J.LeeY. M.et al (2014). Multilineage potential and proteomic profiling of human dental stem cells derived from a single donor.Exp. Cell Res.32092–107. 10.1016/j.yexcr.2013.10.005
135
PierdomenicoL.BonsiL.CalvittiM.RondelliD.ArpinatiM.ChirumboloG.et al (2005). Multipotent mesenchymal stem cells with immunosuppressive activity can be easily isolated from dental pulp.Transplantation80836–842. 10.1097/01.tp.0000173794.72151.88
136
PilbauerovaN.SoukupT.Suchankova KleplovaT.SchmidtJ.SuchanekJ. (2021b). The effect of cultivation passaging on the relative telomere length and proliferation capacity of dental pulp stem cells.Biomolecules11:464. 10.3390/biom11030464
137
PilbauerovaN.SchmidtJ.SoukupT.Koberova IvancakovaR.SuchanekJ. (2021a). The effects of cryogenic storage on human dental pulp stem cells.Int. J. Mol. Sci.22:4432. 10.3390/ijms22094432
138
PisciottaA.RiccioM.CarnevaleG.LuA.De BiasiS.GibelliniL.et al (2015). Stem cells isolated from human dental pulp and amniotic fluid improve skeletal muscle histopathology in mdx/SCID mice.Stem Cell Res Ther.6:156. 10.1186/s13287-015-0141-y
139
PonnaiyanD.BhatK. M.BhatG. S. (2012). Comparison of immuno-phenotypes of stem cells from human dental pulp and periodontal ligament.Int. J. Immunopathol. Pharmacol.25127–134. 10.1177/039463201202500115
140
RaoofM.YaghoobiM. M.DerakhshaniA.Kamal-AbadiA. M.EbrahimiB.AbbasnejadM.et al (2014). A modified efficient method for dental pulp stem cell isolation.Dent. Res. J. (Isfahan)11244–250.
141
RatajczakJ.BronckaersA.DillenY.GervoisP.VangansewinkelT.DriesenR. B.et al (2016). The Neurovascular properties of dental stem cells and their importance in dental tissue engineering.Stem Cells Int.20169762871. 10.1155/2016/9762871
142
RatheeM.JainP. (2021). Embryology, Teeth.Treasure Island, FL: StatPearls.
143
Rodas-JuncoB. A.VillicanaC. (2017). Dental pulp stem cells: current advances in isolation, expansion and preservation.Tissue Eng. Regen. Med.14333–347. 10.1007/s13770-017-0036-3
144
RufasP.JeanneauC.RomboutsC.LaurentP.AboutI. (2016). Complement C3a mobilizes dental pulp stem cells and specifically guides pulp fibroblast recruitment.J. Endod.421377–1384. 10.1016/j.joen.2016.06.011
145
SakaiK.YamamotoA.MatsubaraK.NakamuraS.NaruseM.YamagataM.et al (2012). Human dental pulp-derived stem cells promote locomotor recovery after complete transection of the rat spinal cord by multiple neuro-regenerative mechanisms.J. Clin. Invest.12280–90. 10.1172/JCI59251
146
SanenK.MartensW.GeorgiouM.AmelootM.LambrichtsI.PhillipsJ. (2017). Engineered neural tissue with Schwann cell differentiated human dental pulp stem cells: potential for peripheral nerve repair?J. Tissue Eng. Regen. Med.113362–3372. 10.1002/term.2249
147
SasakiR.AokiS.YamatoM.UchiyamaH.WadaK.OgiuchiH.et al (2011). PLGA artificial nerve conduits with dental pulp cells promote facial nerve regeneration.J. Tissue Eng. Regen. Med.5823–830. 10.1002/term.387
148
SawangmakeC.NowwaroteN.PavasantP.ChansiripornchaiP.OsathanonT. (2014). A feasibility study of an in vitro differentiation potential toward insulin-producing cells by dental tissue-derived mesenchymal stem cells.Biochem. Biophys. Res. Commun.452581–587. 10.1016/j.bbrc.2014.08.121
149
SchellerE. L.ChangJ.WangC. Y. (2008). Wnt/beta-catenin inhibits dental pulp stem cell differentiation.J. Dent. Res.87126–130. 10.1177/154405910808700206
150
SeoB. M.MiuraM.GronthosS.BartoldP. M.BatouliS.BrahimJ.et al (2004). Investigation of multipotent postnatal stem cells from human periodontal ligament.Lancet364149–155. 10.1016/S0140-6736(04)16627-0
151
SharpeP. T. (2016). Dental mesenchymal stem cells.Development1432273–2280. 10.1242/dev.134189
152
ShiS.BartoldP. M.MiuraM.SeoB. M.RobeyP. G.GronthosS. (2005). The efficacy of mesenchymal stem cells to regenerate and repair dental structures.Orthod. Craniofac. Res.8191–199. 10.1111/j.1601-6343.2005.00331.x
153
ShiX.MaoJ.LiuY. (2020). Pulp stem cells derived from human permanent and deciduous teeth: Biological characteristics and therapeutic applications.Stem Cells Transl. Med.9445–464. 10.1002/sctm.19-0398
154
SimonS. R.TomsonP. L.BerdalA. (2014). Regenerative endodontics: regeneration or repair?J. Endod.40S70–S75. 10.1016/j.joen.2014.01.024
155
SmithC. E. (1998). Cellular and chemical events during enamel maturation.Crit. Rev. Oral Biol. Med.9128–161. 10.1177/10454411980090020101
156
SongM.JueS. S.ChoY. A.KimE. C. (2015). Comparison of the effects of human dental pulp stem cells and human bone marrow-derived mesenchymal stem cells on ischemic human astrocytes in vitro.J. Neurosci. Res.93973–983. 10.1002/jnr.23569
157
SongM.LeeJ. H.BaeJ.BuY.KimE. C. (2017). Human dental pulp stem cells are more effective than human bone marrow-derived mesenchymal stem cells in cerebral ischemic injury.Cell Transl.261001–1016. 10.3727/096368916X694391
158
SonoyamaW.LiuY.FangD.YamazaT.SeoB. M.ZhangC.et al (2006). Mesenchymal stem cell-mediated functional tooth regeneration in swine.PLoS One1:e79. 10.1371/journal.pone.0000079
159
SonoyamaW.LiuY.YamazaT.TuanR. S.WangS.ShiS.et al (2008). Characterization of the apical papilla and its residing stem cells from human immature permanent teeth: a pilot study.J. Endod.34166–171. 10.1016/j.joen.2007.11.021
160
StevensA.ZulianiT.OlejnikC.LeRoyH.ObriotH.Kerr-ConteJ.et al (2008). Human dental pulp stem cells differentiate into neural crest-derived melanocytes and have label-retaining and sphere-forming abilities.Stem Cells Dev.171175–1184. 10.1089/scd.2008.0012
161
SunithaV. R.EmmadiP.NamasivayamA.ThyegarajanR.RajaramanV. (2008). The periodontal – endodontic continuum: a review.J. Conserv. Dent.1154–62. 10.4103/0972-0707.44046
162
Syed-PicardF. N.DuY.LathropK. L.MannM. M.FunderburghM. L.FunderburghJ. L. (2015). Dental pulp stem cells: a new cellular resource for corneal stromal regeneration.Stem Cells Transl. Med.4276–285. 10.5966/sctm.2014-0115
163
TanX.DaiQ. (2017). Characterization of microRNAs expression profiles in human dental-derived pluripotent stem cells.PLoS One12:e0177832. 10.1371/journal.pone.0177832
164
TangY.ZhouY.LiH. J. (2021). Advances in mesenchymal stem cell exosomes: a review.Stem Cell Res. Ther.12:71. 10.1186/s13287-021-02138-7
165
TatulloM.MarrelliM.FalisiG.RastelliC.PalmieriF.GargariM.et al (2016). Mechanical influence of tissue culture plates and extracellular matrix on mesenchymal stem cell behavior: a topical review.Int. J. Immunopathol. Pharmacol.293–8. 10.1177/0394632015617951
166
TheryC.ZitvogelL.AmigorenaS. (2002). Exosomes: composition, biogenesis and function.Nat. Rev. Immunol.2569–579. 10.1038/nri855
167
ThesleffI.TummersM. (2008). Tooth Organogenesis And Regeneration.Cambridge, MA: StemBook. 10.3824/stembook.1.37.1
168
TirinoV.PainoF.d’AquinoR.DesiderioV.De RosaA.PapaccioG. (2011). Methods for the identification, characterization and banking of human DPSCs: current strategies and perspectives.Stem Cell Rev. Rep.7608–615. 10.1007/s12015-011-9235-9
169
TirinoV.PainoF.De RosaA.PapaccioG. (2012). Identification, isolation, characterization, and banking of human dental pulp stem cells.Methods Mol. Biol.879443–463. 10.1007/978-1-61779-815-3_26
170
TomicS.DjokicJ.VasilijicS.VucevicD.TodorovicV.SupicG.et al (2011). Immunomodulatory properties of mesenchymal stem cells derived from dental pulp and dental follicle are susceptible to activation by toll-like receptor agonists.Stem Cells Dev.20695–708. 10.1089/scd.2010.0145
171
Tran-HungL.LaurentP.CampsJ.AboutI. (2008). Quantification of angiogenic growth factors released by human dental cells after injury.Arch. Oral Biol.539–13. 10.1016/j.archoralbio.2007.07.001
172
TsutsuiT. W. (2020). Dental pulp stem cells: advances to applications.Stem Cells Cloning1333–42. 10.2147/SCCAA.S166759
173
VizosoF. J.EiroN.CidS.SchneiderJ.Perez-FernandezR. (2017). Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine.Int. J. Mol. Sci.18:1852. 10.3390/ijms18091852
174
WadaN.MenicaninD.ShiS.BartoldP. M.GronthosS. (2009). Immunomodulatory properties of human periodontal ligament stem cells.J. Cell. Physiol.219667–676. 10.1002/jcp.21710
175
WakayamaH.HashimotoN.MatsushitaY.MatsubaraK.YamamotoN.HasegawaY.et al (2015). Factors secreted from dental pulp stem cells show multifaceted benefits for treating acute lung injury in mice.Cytotherapy171119–1129. 10.1016/j.jcyt.2015.04.009
176
WangF.JiaY.LiuJ.ZhaiJ.CaoN.YueW.et al (2017). Dental pulp stem cells promote regeneration of damaged neuron cells on the cellular model of Alzheimer’s disease.Cell Biol. Int.41639–650. 10.1002/cbin.10767
177
WangJ.ZuzzioK.WalkerC. L. (2019). Systemic dental pulp stem cell secretome therapy in a mouse model of amyotrophic lateral sclerosis.Brain Sci.9:165. 10.3390/brainsci9070165
178
WeiW.AoQ.WangX.CaoY.LiuY.ZhengS. G.et al (2020). Mesenchymal stem cell-derived exosomes: a promising biological tool in nanomedicine.Front. Pharmacol.11:590470. 10.3389/fphar.2020.590470
179
WilsonR.UrracaN.SkobowiatC.HopeK. A.MiravalleL.ChamberlinR.et al (2015). Assessment of the tumorigenic potential of spontaneously immortalized and hTERT-Immortalized cultured dental pulp stem cells.Stem Cells Transl. Med.4905–912. 10.5966/sctm.2014-0196
180
WuW.ZhouJ.XuC. T.ZhangJ.JinY. J.SunG. L. (2015). Derivation and growth characteristics of dental pulp stem cells from patients of different ages.Mol. Med. Rep.125127–5134. 10.3892/mmr.2015.4106
181
XuB.FanD.ZhaoY.LiJ.WangZ.WangJ.et al (2019). Three-dimensional culture promotes the differentiation of human dental pulp mesenchymal stem cells into insulin-producing cells for improving the diabetes therapy.Front. Pharmacol.10:1576. 10.3389/fphar.2019.01576
182
XuB.YuanF. Z.LinL.YeJ.FanB. S.ZhangJ. Y.et al (2020). The higher inherent therapeutic potential of biomaterial-based hDPSCs and hEnSCs for pancreas diseases.Front. Bioeng. Biotechnol.8:636. 10.3389/fbioe.2020.00636
183
Yagi MendozaH.YokoyamaT.TanakaT.IiH.YaegakiK. (2018). Regeneration of insulin-producing islets from dental pulp stem cells using a 3D culture system.Regen. Med.13673–687. 10.2217/rme-2018-0074
184
YamadaY.NakamuraS.ItoK.SugitoT.YoshimiR.NagasakaT.et al (2010). A feasibility of useful cell-based therapy by bone regeneration with deciduous tooth stem cells, dental pulp stem cells, or bone-marrow-derived mesenchymal stem cells for clinical study using tissue engineering technology.Tissue Eng. Part A161891–1900. 10.1089/ten.tea.2009.0732
185
YamadaY.Nakamura-YamadaS.KusanoK.BabaS. (2019). Clinical potential and current progress of dental pulp stem cells for various systemic diseases in regenerative medicine: a concise review.Int. J. Mol. Sci.20:1132. 10.3390/ijms20051132
186
YamamotoT.OsakoY.ItoM.MurakamiM.HayashiY.HoribeH.et al (2016). Trophic effects of dental pulp stem cells on schwann cells in peripheral nerve regeneration.Cell Trans.25183–193. 10.3727/096368915X688074
187
YangC.LiX.SunL.GuoW.TianW. (2017). Potential of human dental stem cells in repairing the complete transection of rat spinal cord.J. Neural Eng.14:026005. 10.1088/1741-2552/aa596b
188
YangH.ShinS.AhnJ.ChoiY.KimK. H.ChungC. J. (2013). Local injection of pulp cells enhances wound healing during the initial proliferative phase through the stimulation of host angiogenesis.J. Endod.39788–794. 10.1016/j.joen.2013.01.011
189
YangK. L.ChenM. F.LiaoC. H.PangC. Y.LinP. Y. (2009). A simple and efficient method for generating Nurr1-positive neuronal stem cells from human wisdom teeth (tNSC) and the potential of tNSC for stroke therapy.Cytotherapy11606–617. 10.1080/14653240902806994
190
YeQ.WangH.XiaX.ZhouC.LiuZ.XiaZ. E.et al (2020). Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II).Trials21:520.
191
YildirimS.ZibandehN.GencD.OzcanE. M.GokerK.AkkocT. (2016). The comparison of the immunologic properties of stem cells isolated from human exfoliated deciduous teeth, dental pulp, and dental follicles.Stem Cells Int.2016:4682875. 10.1155/2016/4682875
192
YuS.ZhaoY.MaY.GeL. (2016). Profiling the secretome of human stem cells from dental apical papilla.Stem Cells Dev.25499–508. 10.1089/scd.2015.0298
193
ZhaiQ.DongZ.WangW.LiB.JinY. (2019). Dental stem cell and dental tissue regeneration.Front. Med.13:152–159. 10.1007/s11684-018-0628-x
194
ZhangW.WalboomersX. F.ShiS.FanM.JansenJ. A. (2006). Multilineage differentiation potential of stem cells derived from human dental pulp after cryopreservation.Tissue Eng.122813–2823. 10.1089/ten.2006.12.2813
195
ZhangW.WalboomersX. F.Van KuppeveltT. H.DaamenW. F.Van DammeP. A.BianZ.et al (2008). In vivo evaluation of human dental pulp stem cells differentiated towards multiple lineages.J. Tissue Eng. Regen. Med.2117–125. 10.1002/term.71
196
ZhaoH.FengJ.SeidelK.ShiS.KleinO.SharpeP.et al (2014). Secretion of shh by a neurovascular bundle niche supports mesenchymal stem cell homeostasis in the adult mouse incisor.Cell Stem Cell14160–173. 10.1016/j.stem.2013.12.013
197
ZhaoY.WangL.JinY.ShiS. (2012). Fas ligand regulates the immunomodulatory properties of dental pulp stem cells.J. Dent. Res.91948–954. 10.1177/0022034512458690
198
ZhengL.EhardtL.McAlpinB.AboutI.KimD.PapagerakisS.et al (2014). The tick tock of odontogenesis.Exp. Cell Res.32583–89. 10.1016/j.yexcr.2014.02.007
199
ZhouD.GanL.PengY.ZhouY.ZhouX.WanM.et al (2020). Epigenetic regulation of dental pulp stem cell fate.Stem Cells Int.2020:8876265. 10.1155/2020/8876265
200
ZhouH.LiX.YinY.HeX. T.AnY.TianB. M.et al (2020). The proangiogenic effects of extracellular vesicles secreted by dental pulp stem cells derived from periodontally compromised teeth.Stem Cell Res. Ther.11:110. 10.1186/s13287-020-01614-w
Summary
Keywords
dental pulp stem cells, surface markers, heterogeneity, immunomodulation, hepatogenic and pancreatic differentiation, human DPSCs
Citation
Al Madhoun A, Sindhu S, Haddad D, Atari M, Ahmad R and Al-Mulla F (2021) Dental Pulp Stem Cells Derived From Adult Human Third Molar Tooth: A Brief Review. Front. Cell Dev. Biol. 9:717624. doi: 10.3389/fcell.2021.717624
Received
31 May 2021
Accepted
15 September 2021
Published
12 October 2021
Volume
9 - 2021
Edited by
Jianyong Xu, Shenzhen University, China
Reviewed by
Marco Tatullo, University of Bari Medical School, Italy; Miguel Barajas, Public University of Navarre, Spain; Yan Xu, Third Affiliated Hospital of Sun Yat-sen University, China
Updates
Copyright
© 2021 Al Madhoun, Sindhu, Haddad, Atari, Ahmad and Al-Mulla.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ashraf Al Madhoun, ashraf.madhoun@dasmaninstitute.orgRasheed Ahmad, rasheed.ahmad@dasmaninstitute.org
†These authors have contributed equally to this work
This article was submitted to Stem Cell Research, a section of the journal Frontiers in Cell and Developmental Biology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.